1. Introduction {#sec1-biomolecules-09-00269}
===============

Parkinson's disease (PD) is a common neurodegenerative disorder (ND) \[[@B1-biomolecules-09-00269]\]. It is characterized by neuronal cell loss in the substantia nigra (SN), which leads to a progressive central nervous system dysfunction. Symptoms include motor abnormalities like tremors, movement and balance issues, and non-motor problems like difficulty in swallowing and speaking, depression, cognitive impairment, and dementia. Although PD by itself is not a fatal disease, people may die from causes related to it.

Age is the most relevant risk factor: approximately 2% of people over the age of 60 years, and 3% of those at age over 80 years, suffer from PD \[[@B2-biomolecules-09-00269]\]. Due to the average population aging, the occurrence of PD and of other NDs like Alzheimer's disease and Amyotrophic Lateral Sclerosis is continuously increasing. The number of persons suffering from PD is expected to reach a value of approximately 9 million in 2030 \[[@B3-biomolecules-09-00269]\] and up to more than 17 million in 2040 \[[@B4-biomolecules-09-00269]\]. NDs are considered the leading source of disability around the world, and the fastest growing of these disorders is PD \[[@B5-biomolecules-09-00269]\]. Although non-infectious, PD exhibits many of the characteristics of a pandemic, and it is experiencing exponential growth worldwide \[[@B4-biomolecules-09-00269],[@B6-biomolecules-09-00269],[@B7-biomolecules-09-00269]\]. Together with the average population age increasing, other factors will likely contribute to increase the incidence of PD over current forecasts. In particular, reducing smoking rates in some countries may lead to a higher incidence of PD, because many studies have found that the risk of this disease is decreased among smokers by approximately 40% \[[@B8-biomolecules-09-00269]\]. Also, pollutants by-produced in industrialized countries may contribute to the rising rates of PD, because specific pesticides, solvents, and heavy metals have been linked to this disease \[[@B9-biomolecules-09-00269]\]. Actually, countries that underwent the most rapid industrialization have seen the greatest increase in the rates of PD \[[@B5-biomolecules-09-00269]\].

PD can be due to genetic factors, and it has been found that race/ethnicity can affect the incidence of PD in the order Hispanics \> non-Hispanic Whites \> Asians \> Blacks \[[@B10-biomolecules-09-00269]\]. However, genetics appears to justify only a small amount (approximately 5--10%) of all PD cases: it is therefore possible to suggest an important role of external factors, like behavioural and environmental \[[@B2-biomolecules-09-00269],[@B9-biomolecules-09-00269],[@B11-biomolecules-09-00269]\].

Existing drugs for PD provide only the relief of some symptoms, and there are no disease-modifying therapies demonstrated to slow or to stop the ongoing neurodegenerative process. In the search for such therapies, however, the primary issue lies in the multifactorial nature of PD. The main neuropathological hallmark of PD is proteopathy, as the formation and deposition of protein aggregates is generally observed in PD brains. The most typical deposits, called Lewy bodies, are due to α-synuclein (α-syn), an abundant neurological protein with yet unclear physiological functions. Other features characterizing PD brains are mitochondrial dysfunction, oxidative stress, defects in energy metabolism, aberrant axonal transport, and metal ion dyshomeostasis \[[@B12-biomolecules-09-00269]\]. All the pathways operating in PD appear to be strictly inter-related, so that both the study of the molecular causes of the disease, and the search for an efficient therapy, cannot be limited to a specific pathway: a multi-targeted approach is suggested \[[@B1-biomolecules-09-00269],[@B12-biomolecules-09-00269]\]. Much scientific effort in recent years is devoted to the comprehension of each pathological mechanism operating in PD, with the aim to understand and rationalize the biochemical processes occurring during the pathology. This review focuses on metal dyshomeostasis and on the therapy that is aimed to target this pathological process, i.e., metal chelation therapy.

2. Parkinson's Disease and Metal Ions {#sec2-biomolecules-09-00269}
=====================================

Almost one hundred years ago, Lhermitte et al. \[[@B13-biomolecules-09-00269]\] discovered that the brains of people who died from Parkinsonism, a form of dementia with similar symptoms as those of PD \[[@B14-biomolecules-09-00269]\], contained a significantly larger amount of iron (Fe) than the corresponding brains of controls. Since that work, several studies have confirmed the abnormally high Fe content also in the brains of PD patients \[[@B15-biomolecules-09-00269],[@B16-biomolecules-09-00269],[@B17-biomolecules-09-00269],[@B18-biomolecules-09-00269],[@B19-biomolecules-09-00269]\]. Conversely, other studies could not detect an overload of Fe in PD brains \[[@B20-biomolecules-09-00269],[@B21-biomolecules-09-00269]\]. Recently, several studies have attempted to determine Fe brain levels in living patients with PD (\[[@B22-biomolecules-09-00269],[@B23-biomolecules-09-00269]\] and references therein). Most but not all studies indicated larger Fe levels in the SN of patients with PD compared to control subjects, whereas no Fe excess was observed in many other brain parts, thus suggesting that a Fe dyshomeostasis occurs in PD brain, especially in the SN \[[@B23-biomolecules-09-00269],[@B24-biomolecules-09-00269]\]. Bush et al. found that the reported Fe accumulation is contributed to by a disturbance in Fe export. This was explained by a significant reduction of the specific activity (but not of the levels) of ceruloplasmin in the SN of PD patients \[[@B25-biomolecules-09-00269]\]. Ceruloplasmin is a multicopper ferroxidase protein facilitating cellular Fe export \[[@B26-biomolecules-09-00269]\]. The same authors \[[@B27-biomolecules-09-00269]\] observed a decrease in the PD SN of the soluble levels of another protein, tau, which can lower neuronal Fe levels by promoting the presentation of the amyloid protein precursor to the neuronal surface, where it favours the efflux of Fe \[[@B28-biomolecules-09-00269]\]. It has also been suggested that PD-induced Fe accumulation is due to a dark pigment contained in SN, neuromelanin, that is able to bind Fe and that may act as a protection against Fe by binding and storing its excessive labile content \[[@B29-biomolecules-09-00269]\].

A number of studies have also shown alterations in the copper (Cu) concentrations in the brain of post-mortem PD patients compared to non-PD controls \[[@B11-biomolecules-09-00269],[@B30-biomolecules-09-00269]\], suggesting that metal dyshomeostasis in PD brains also regards Cu \[[@B31-biomolecules-09-00269]\]. However, while Fe appeared to be systematically overloaded, Cu was significantly reduced in the degenerating regions of PD brains \[[@B30-biomolecules-09-00269],[@B32-biomolecules-09-00269],[@B33-biomolecules-09-00269],[@B34-biomolecules-09-00269]\]. Other metal ions have been monitored in PD brains, but less definite results were reported. Conflicting data were reported for zinc (Zn) \[[@B35-biomolecules-09-00269],[@B36-biomolecules-09-00269]\] and Genoud et al. recently evidenced no differences in Zn levels between experimental groups \[[@B30-biomolecules-09-00269]\]. Parkinsonism is reported to rapidly develop in patients subjected to the exposure of high levels of manganese (Mn) \[[@B11-biomolecules-09-00269],[@B37-biomolecules-09-00269]\], and a role in Parkinsonism onset has also been suggested for Cu \[[@B38-biomolecules-09-00269]\]. However, no changes have been detected in the Mn level of post-mortem PD brains with respect to non-PD samples \[[@B30-biomolecules-09-00269]\], and, as seen, even reduced levels were detected for Cu. Other elements which have been occasionally linked with PD have been aluminium (Al), arsenic (As), bismuth (Bi), cadmium (Cd), mercury (Hg), lead (Pb), thallium (Tl), and titanium (Ti) \[[@B2-biomolecules-09-00269],[@B11-biomolecules-09-00269]\]. Bjørklund et al. \[[@B11-biomolecules-09-00269]\] reviewed the works in which the exposure to metal ions was shown to correlate with the onset of PD and/or of Parkinsonism.

These results have prompted researchers to clarify the role of each metal ion in PD. In literature, the most studied metal ions have been Fe, Cu, Mn and Zn, whereas papers regarding other elements were much fewer. The huge work performed on this matter has been reviewed in detail \[[@B11-biomolecules-09-00269],[@B31-biomolecules-09-00269],[@B32-biomolecules-09-00269],[@B39-biomolecules-09-00269],[@B40-biomolecules-09-00269],[@B41-biomolecules-09-00269]\], and it regarded the molecular mechanisms and biological aspects of these elements in the brains of controls and of PD patients.

Essential metal ions like Cu, Fe, Mn, and Zn are known to be involved in a large number of biochemical processes in the human brain \[[@B41-biomolecules-09-00269],[@B42-biomolecules-09-00269]\], where they exert a structural (e.g., stabilizing configurations of macromolecules) or a functional role (e.g., being the active site of metalloenzymes). Both Cu and Fe can exist in vivo under two oxidation states, Cu(II) and Cu(I), Fe(III) and Fe(II), to allow biological systems activating and using O~2~ for energy purposes. Reactions activating O~2~, if not tightly regulated, can cause oxidative stress, so that healthy biological systems contain suitable antioxidants and very little exchangeable Cu and Fe ions. This metal ion fraction is also called "labile" or "free" ion \[[@B43-biomolecules-09-00269]\], and it is thought to be the main contributor of metal-induced oxidative stress \[[@B24-biomolecules-09-00269],[@B44-biomolecules-09-00269],[@B45-biomolecules-09-00269]\]. Metal ions in the labile pool can be loosely bound to peptides, carboxylates and phosphates as compounds with low mass, while some might exist as hydrated free ions. In healthy mammalian cells, the labile Fe concentration is less than 1 µmol/L, and less than 5% of total Fe \[[@B46-biomolecules-09-00269]\]. The labile Cu and Fe fractions exert their toxicity by generating reactive oxygen species (ROS) via the Fenton and the Haber--Weiss reactions, both related to the presence of the Fe(III)/Fe(II) or of the Cu(II)/Cu(I) redox couple. The Fenton reaction for Fe is:
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In PD brains, a dysregulation occurs between the production of OH• and OOH• (and of other ROS) and their removal, thus resulting in cellular damage through the oxidation of lipids, proteins, and DNA. The levels of glutathione, one of the most important antioxidants in human brain, were reported to be significantly decreased in the SN of PD patients compared with those of healthy subjects \[[@B47-biomolecules-09-00269]\]. A dyshomeostasis of Fe or Cu can therefore have a significant impact on ROS regulation. Also, high labile Mn levels have been reported to increase oxidative stress \[[@B42-biomolecules-09-00269]\]. Labile Zn^2+^ is more abundant in healthy brain cells, as it is released by neural activity at many central excitatory synapses \[[@B48-biomolecules-09-00269]\], but still this metal ion was related to oxidative stress \[[@B49-biomolecules-09-00269]\].

Labile metal ion pools can also undergo a pathogenic relation with α-syn. Being an unfolded protein, α-syn can easily switch in a number of conformational states in response to changes in environmental conditions \[[@B50-biomolecules-09-00269],[@B51-biomolecules-09-00269]\]. Temperature changes, presence of pro-oxidative conditions \[[@B52-biomolecules-09-00269],[@B53-biomolecules-09-00269]\] and of several metal ions can promote the formation of dimers and other polymeric forms of this protein \[[@B54-biomolecules-09-00269],[@B55-biomolecules-09-00269]\]. The misfolding of α-syn is thought to be the most important factor driving the formation of Lewy bodies in PD, and, in turn, toxic forms of aggregated α-syn are released from neurons, and then spread between cells in a prion-like manner \[[@B32-biomolecules-09-00269]\]. It was shown that part of RNA structure posttranscriptionally regulates α-syn production in response to cellular Fe and redox events \[[@B56-biomolecules-09-00269],[@B57-biomolecules-09-00269]\], so that the overexpression of α-syn promotes the neuronal accumulation of Fe. Fe can promote the aggregation of this protein, and post-translational modifications of α-syn have also been found to regulate Fe transport \[[@B58-biomolecules-09-00269]\]. It was found that α-syn can inhibit the lysosome-mediated degradation of ferritin (a Fe storing protein), resulting in the intracellular build-up of ferritin and consequently of Fe \[[@B59-biomolecules-09-00269]\]. Also, the direct interaction between metal ions and α-syn in neurons, with the formation of metal--protein complexes, can be of primary importance to justify the protein unfolding and eventually its aggregation. Furthermore, the complexes themselves may be cytotoxic, as, e.g., it was reported to be Cu^2+^/α-syn \[[@B60-biomolecules-09-00269]\]. The properties of the complex formation between metal ions and α-syn have been reviewed by several authors (e.g., \[[@B12-biomolecules-09-00269],[@B32-biomolecules-09-00269],[@B60-biomolecules-09-00269],[@B61-biomolecules-09-00269]\]). As regards the binding moiety, it is known that metal ions can bind to high-affinity N-terminal (containing residues 1--60) and to lower affinity C-terminal sites of α-syn (from 96 to 140 amino acid residues). Studies have been performed to evaluate the stability of the metal--α-syn interactions: information available in the literature, given as dissociation constants (*K*~d~, see below) of the complexes formed between metal ions and α-syn, is resumed in [Table 1](#biomolecules-09-00269-t001){ref-type="table"}.

A recently discovered cell death pathway, called ferroptosis or Fe-dependent cell death, has provided further impetus to the "Fe hypothesis" of PD, Alzheimer's disease, and Amyotrophic lateral sclerosis \[[@B39-biomolecules-09-00269],[@B62-biomolecules-09-00269],[@B63-biomolecules-09-00269]\]. Fe still has an unclear role in ferroptosis, but it has been shown that Fe chelation is beneficial in preventing this cellular damage, which is also characterized by increased levels of lipid hydroperoxides and by a depletion of the important antioxidant glutathione. PD has been linked to ferroptosis because literature studies generally indicate that ferroptosis inhibitors may be effective in PD, too \[[@B39-biomolecules-09-00269]\]. For example, chelation therapy can be beneficial in PD (see below), and prodrugs such as *N*-acetylcysteine, which enhances glutathione levels in brain, exert partial protection against PD neurodegeneration.

Many mechanisms have been considered and reviewed for the damage induced by Cu \[[@B44-biomolecules-09-00269]\], Fe \[[@B49-biomolecules-09-00269],[@B64-biomolecules-09-00269],[@B65-biomolecules-09-00269],[@B66-biomolecules-09-00269]\], Mn \[[@B67-biomolecules-09-00269]\] and Zn \[[@B49-biomolecules-09-00269]\] under PD conditions; in several cases, oxidative damage, metal dyshomeostasis and α-syn aggregation have been demonstrated to be strictly related to each other.

Despite the availability of many useful results, the molecular pathways describing the association between metals and PD onset are still ill defined. It remains controversial whether the dyshomeostasis of Cu, Fe, Mn, Zn, and possibly of other elements, is the primary cause or secondary consequence of PD as well as of other neurological diseases such as Alzheimer's disease, multiple system atrophy, dementia with Lewy bodies, amyotrophic lateral sclerosis, Huntington's disease, frontotemporal dementia, corticobasal degeneration, and progressive supranuclear palsy. The possibility that metal dyshomeostasis is just a secondary consequence of other independent molecular paths is supported by considering that the timing for PD onset is much slower (many years) than for Parkinsonism, which in turn is very rapidly induced if, e.g., Mn or other external toxins are administered to animal models. This suggests that endogenous neurotoxins, rather than exogenous ones, are responsible for the extremely slow neurodegeneration observed in PD. In their very recent review, Ndayisaba et al. tried to answer whether neurodegeneration is caused (or co-caused) by Fe dyshomeostasis, whether the latter contributes accelerating the pathological effects due to nerve cell death and to release of intracellular components, or whether neurodegeneration is simply not related to Fe accumulation \[[@B68-biomolecules-09-00269]\]. The authors were not able to give a definite answer, but they observed that Fe dyshomeostasis occurs already at early PD onset, and that Fe should at least contribute to many aspects of neurodegeneration, in a way such that Fe might be proposed as a biomarker to detect for preclinical stages of NDs. Similarly, prudent conclusions have been drawn in another very recent review by Chen et al. \[[@B42-biomolecules-09-00269]\], where the authors found that it was unclear whether Fe and Mn are primary or secondary causes of neurodegeneration, as they found that neurodegeneration cannot be reversed if metal overload is removed. The question about the primary or secondary role of Cu and Zn was raised by Barnham and Bush \[[@B41-biomolecules-09-00269]\] in their review. They concluded that PD, Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis are not caused by a simple overload of these metals, although the possibility that exposure may alter disease risk was not excluded. The authors found a number of possible molecular pathways induced by altered Cu and Zn levels in PD brains, which can at least contribute to the disease progression. The authors concluded that "the targets of metalloneurobiology are rich with pharmacological opportunities" \[[@B41-biomolecules-09-00269]\].

3. Metal Chelation Therapy in Parkinson's Disease {#sec3-biomolecules-09-00269}
=================================================

Metal chelation therapy (MCT) was proposed more than 50 years ago for the therapy of pathologies produced in the body by an overload of a metal. Metal chelation therapy involves the use of a chelating agent (CA), i.e., a molecule which forms stable coordination complexes with the target metal ion. Once administered to the patient, the CA acts as a scavenger removing the metal from its stores and favouring its decorporation from the body \[[@B69-biomolecules-09-00269]\]. An efficient CA should be orally active and have a low cost, and both the ligand and the complexes formed in vivo should possess suitable hydrophilicity/hydrophobicity, and no redox activity \[[@B70-biomolecules-09-00269]\]. In particular, the CA affinity towards the overloaded metal ion should be as high as possible. Last but not least, CAs and their metal complexes should display no toxicity and no or negligible side effects, but these properties are still only partially verified for established CAs. For example, the common Fe and Al chelator Desferrioxamine (also known as Desferal, DFO or Deferoxamine) is reported to cause a number of severe side effects \[[@B71-biomolecules-09-00269]\], among which heart diseases \[[@B72-biomolecules-09-00269]\] and retinopathy \[[@B73-biomolecules-09-00269]\] appear to be the most important ones. Adverse effects were also reported for the other two established Fe chelators, Deferiprone and Deferasirox. According to Fisher et al. \[[@B74-biomolecules-09-00269]\], side effects increased in patients treated with Deferiprone compared with Desferrioxamine. Kontoghiorghes et al. \[[@B71-biomolecules-09-00269],[@B75-biomolecules-09-00269]\] reported a number of fatal renal, liver, and bone marrow failures due to Deferasirox. Another common CA used for Cu overload, D-Penicillamine, causes neuropsychiatric or hepatic complications in up to one-third of patients \[[@B76-biomolecules-09-00269]\]. Toxic effects have also been observed with other CAs (2,3-dimercaptopropanol, meso-2,3-dimercaptosuccinic acid, 2,3-dimercaptopropane-1-sulfonic acid, EDTA calcium or sodium salts) used in the therapy for the overload of As, Au, Hg, Pb \[[@B77-biomolecules-09-00269]\].

Despite these toxicity reports, the occurrence of a metal ion dyshomeostasis in PD has suggested to also employ MCT for the therapy of this disease and of other NDs such as corticobasal degeneration, the Westfal variant of Huntington's disease, Alzheimer's disease, Friedreich's ataxia, pantothenate kinase-associated neurodegeneration, and other neuropathologies associated with brain metal overload \[[@B12-biomolecules-09-00269],[@B24-biomolecules-09-00269],[@B78-biomolecules-09-00269],[@B79-biomolecules-09-00269]\]. In these cases, MCT was also referred to as "metal targeting", "metal attenuating" or "metal protein attenuating" \[[@B41-biomolecules-09-00269],[@B80-biomolecules-09-00269],[@B81-biomolecules-09-00269]\], in order to underline the differences occurring when MCT is employed in NDs instead of in metal overloads. Poujois et al. \[[@B82-biomolecules-09-00269]\] have further improved this chelation strategy, and they called it "conservative chelation". For the design of metal-based therapeutic strategies in NDs, the complete removal of metals from affected tissues is not the desired mechanism of action of these drugs. The terms "targeting", "attenuating" and "conservative" evidence that the CA should remove only labile essential metal ions, which are considered to be not functionally required. Essential metal ions are aimed to be removed from the biological targets where they might be harmful, in particular, to avoid the α-syn complex formation and ROS-generating redox reactions, but they should also be allowed acting their normal physiological functions, as for example in metallo-enzymes, thus preventing severe side effects. Another important feature of a conservative CA is that the labile metal pool should be redeployed to cell acceptors or transport proteins (e.g., transferrin for Fe) \[[@B82-biomolecules-09-00269]\]. This mode of action is expected to correct aberrant metal distribution, minimising systemic loss of chelated metal, thus avoiding the CA to cause metal-deficiency anemia and interfere with metal-dependent mechanisms essential for normal physiological functions. Conservative chelation, instead of a more aggressive metal removal, appeas to be particularly suitable in PD if Fe is the target, as patients suffering from this ND are mainly elderly people who are often on the border or already with Fe deficiency. Nevertheless, the unspecific removal of any essential trace metals may lead to harmful adverse effects to people of all ages, and metal deficiency can be regarding not only targeted but also untargeted metal ions. Excessive removal of Cu and Zn has been often reported for β-thalassemic patients undergoing MCT with Fe-chelators such as Deferiprone, and especially Desferrioxamine and Deferasirox \[[@B83-biomolecules-09-00269],[@B84-biomolecules-09-00269]\]. Cu and Zn anemia, in turn, can lead to delay in growth and development, immunodeficiency, and abnormal hematopoiesis \[[@B84-biomolecules-09-00269]\]. Metal redistribution, rather than metal removal, is therefore the goal in PD \[[@B24-biomolecules-09-00269],[@B85-biomolecules-09-00269]\]. To allow a conservative chelation, a CA to be employed in PD should form moderate but not too strong complexes with the target metal ion. As an additional property, the drug should be able to pass the blood--brain barrier \[[@B78-biomolecules-09-00269]\]. The ability of a CA to pass this barrier can be improved by the prochelator strategy, which for PD and also for other pathologies has been extensively reviewed by Oliveri and Vecchio \[[@B86-biomolecules-09-00269]\].

In PD, MCT was proposed to target dysregulated essential metal ions \[[@B85-biomolecules-09-00269]\], mainly the labile pool of Fe and Cu \[[@B24-biomolecules-09-00269],[@B78-biomolecules-09-00269]\] but also of Zn \[[@B81-biomolecules-09-00269]\] and, more rarely, of Mn \[[@B40-biomolecules-09-00269]\], rather than for the decorporation of total toxic ions such as Al, Hg, Pb, etc. MCT has been tested in a number of translational studies on cell lines or on animal PD models, where Parkinsonism was induced by the administration of OHDA (6-hydroxydopamine) or MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). The Fe chelator Desferrioxamine was reported to reduce iron-induced oxidative stress in SK-N-SH cell line and dopaminergic cells aggregation \[[@B87-biomolecules-09-00269]\], and its intranasal administration significantly improved PD symptoms in MPTP-treated mice \[[@B88-biomolecules-09-00269]\]. The other Fe chelator Deferiprone, differently than Desferrioxamine, is orally active and is better able to cross the blood--brain barrier \[[@B89-biomolecules-09-00269]\]. Deferiprone demonstrated to be efficacious in MPTP and OHDA-induced animal models of PD \[[@B90-biomolecules-09-00269]\]. Other CAs tested in cell lines or in animal models for the PD therapy have been Clioquinol \[[@B91-biomolecules-09-00269]\], VK-28 \[[@B92-biomolecules-09-00269],[@B93-biomolecules-09-00269]\], M30 \[[@B94-biomolecules-09-00269]\], PBT2 \[[@B95-biomolecules-09-00269]\], Q1, Q4 \[[@B96-biomolecules-09-00269]\] and several other compounds, as reviewed recently by Singh et al. \[[@B89-biomolecules-09-00269]\].

The first clinical evidence about the efficacy of a conservative Fe chelation regimen for human PD was given by Devos et al. \[[@B90-biomolecules-09-00269]\], who orally administered Deferiprone to PD patients for 12 months. The Fe deposits in the SN were significantly reduced, and the Unified Parkinson's Disease Rating Scale motor indicators of disease progression were significantly improved. However, when the treatment was suspended, Fe started to accumulate again, suggesting a reversal to the pathological state. Deferiprone, differently than other well-known Fe chelators such as Desferrioxamine and Desferal, has the important feature to rescue transfusional hemosiderosis in the hearts of β-thalassemia patients without inducing significant anemia, largely attributable to the redeployment of captured Fe to extracellular iron-free transferrin and subsequent distribution \[[@B97-biomolecules-09-00269]\], thus allowing this CA to be employed for a conservative chelation strategy. Devos et al. \[[@B90-biomolecules-09-00269]\] reported that none of the Deferiprone-treated PD patients developed new neurological signs, and no level changes (of Fe and of other transition metals) were detected in brain parts not involved in PD. The conservative chelation strategy used by the authors prevented side effects typically due to Fe-deficiency anemia in the brain such as the restless legs syndrome \[[@B98-biomolecules-09-00269]\]. Other Fe chelators forming stronger complexes with the targeted metal ion could have caused such unwanted side effects as they would likely also remove the non-labile part of Fe or of other metal ions \[[@B90-biomolecules-09-00269]\]. The authors concluded that Deferiprone can represent a paradigm for conservative Fe chelation. The encouraging results obtained for this CA prompted the development of other clinical trials with Deferiprone. A search in <https://clinicaltrials.gov> indicated four ongoing or finished tests of this molecule for the treatment of PD, as also recently reported by Nuñez and Chana-Cuevas \[[@B79-biomolecules-09-00269]\].

To the best of our knowledge, no other CA is still being subjected to clinical trials. However, other than Deferiprone, there is a number of molecules which have been or are being considered good therapeutic candidates for PD therapy \[[@B24-biomolecules-09-00269],[@B79-biomolecules-09-00269],[@B85-biomolecules-09-00269],[@B89-biomolecules-09-00269]\]. Nowadays, due to the multi-faced nature of PD, the proposed strategy for MCT requires the use of multifunctional molecules able not only to bind metal ions thus controlling metal dyshomeostasis, but also to counterbalance other toxic pathways in PD. Multifunctional molecules for PD have recently been reviewed by Savelieff et al. \[[@B12-biomolecules-09-00269]\].

All previously cited reviews list the names and sometimes the chemical structures of CAs used as or tested for PD therapy. However, these reviews do not report which complexes can form between relevant metal ions and CAs (metal--ligand stoichiometries) and how stable they are (metal--ligand stability constants), i.e., they lack speciation information. Some lists of metal--ligand stoichiometries and of stability constants (given as log*β*, see below) for promising PD drugs have been reported, for example by Gumienna-Kontecka et al. \[[@B24-biomolecules-09-00269]\], Kasprzak et al. \[[@B99-biomolecules-09-00269]\], and Prachayasittikul et al. \[[@B100-biomolecules-09-00269]\]. The Gumienna-Kontecka log*β* list was however limited to very few compounds and to the complexes formed with Fe(III), the Kasprzak and Prachayasittikul lists report only the complex formation of flavonoids and 8-hydroxyquinolines, respectively. Many of the reported lists also lack the ligand acidity constants, which (see below) are necessary to achieve a complete speciation picture.

The knowledge of metal--ligand speciation can allow modeling the CA activity in vitro or in vivo, i.e., to perform calculations (e.g., \[[@B101-biomolecules-09-00269]\]) describing the distribution of the metal ion of interest at any conditions. Some examples of information which can be gathered from speciation calculations in the frame of MCT will be briefly given below. We think, and it has been stated (see, e.g., \[[@B101-biomolecules-09-00269],[@B102-biomolecules-09-00269]\]), that knowledge about metal--ligand speciation should be easily available to researchers interested in the study of pathologies involving metal ions, such as PD. As regards CAs, the aforementioned knowledge should at first regard all essential metal ions (in all their possible oxidation states) undergoing dyshomeostasis in PD. The relevant ions are therefore Cu(II), Cu(I), Fe(III), Fe(II), Mn(II), and Zn(II) (Mn(III) should also be considered in principle, however we decided to exclude it because its content in the body is generally considered to be minimal \[[@B103-biomolecules-09-00269]\]).

It is also necessary to note that there are several other established or promising PD drugs, not specifically designed for MCT, which can also act as CAs. A typical example is L-Dopa (levodopa), the gold standard in the therapy against PD: its pharmacological activity is aimed to increase the dopamine deficit in vivo, but it can also form stable complexes with several metal ions including the PD relevant ones \[[@B104-biomolecules-09-00269]\]. These compounds are by themselves multifunctional drugs, and their potential influence on the pathological mechanisms involving metal ions cannot be neglected. In the present review, all drugs displaying metal chelation properties, not only those specifically designed for MCT, will be considered.

A bibliographic search has been performed with the aim to collect all promising and established drugs for the PD therapy. Keywords and boolean logics employed for this bibliographic search are given in the [Supplementary Materials](#app1-biomolecules-09-00269){ref-type="app"}. Several reviews appeared in 2014 or later, reporting lists of anti-PD compounds \[[@B1-biomolecules-09-00269],[@B12-biomolecules-09-00269],[@B105-biomolecules-09-00269],[@B106-biomolecules-09-00269],[@B107-biomolecules-09-00269],[@B108-biomolecules-09-00269],[@B109-biomolecules-09-00269],[@B110-biomolecules-09-00269]\]. These reviews list mainly molecules in use, or which underwent in vivo, or clinical phase tests against PD; here, we also decided to consider compounds which have just been tested in vitro, or even only proposed, e.g., after an in silico approach, because it is likely that some of these will undergo further tests in the following years. Clearly, if a compound was proposed and/or tested in vitro several years ago, and after not more considered as anti-PD drug, likely it was not suitable for this aim and has been abandoned. Due to the latter consideration, and given the availability of the above listed reviews, we decided to limit our bibliographic search to papers published starting from 2014.

For each compound, name(s), chemical structure and the reference(s) were collected. The whole list of these substances is reported in [Table S1 of the Supplementary Materials](#app1-biomolecules-09-00269){ref-type="app"}. This table lists approximately 800 compounds and, to the best of our knowledge, it is the most complete table available to date which reports established or potential anti-PD drugs. [Table S1](#app1-biomolecules-09-00269){ref-type="app"} also contains the compounds listed in all above mentioned reviews of PD drugs \[[@B1-biomolecules-09-00269],[@B12-biomolecules-09-00269],[@B24-biomolecules-09-00269],[@B79-biomolecules-09-00269],[@B85-biomolecules-09-00269],[@B89-biomolecules-09-00269],[@B104-biomolecules-09-00269],[@B105-biomolecules-09-00269],[@B106-biomolecules-09-00269],[@B107-biomolecules-09-00269],[@B108-biomolecules-09-00269],[@B109-biomolecules-09-00269],[@B110-biomolecules-09-00269]\]. [Table S1](#app1-biomolecules-09-00269){ref-type="app"} does not report natural extracts, e.g., drugs obtained from plants or animals, unless the active components have been identified. This therapeutic approach is extensively considered in the literature: for a recent review see, e.g., \[[@B111-biomolecules-09-00269]\].

[Table 2](#biomolecules-09-00269-t002){ref-type="table"} represents a subset of [Table S1](#app1-biomolecules-09-00269){ref-type="app"} and it lists all compounds (nearly 250) displaying metal-chelating properties which have been used, tested or only proposed for the therapy against PD.

It is rather easy to predict whether a given compound can form stable complexes with metal ions, and thus whether it in principle can affect metal homeostasis in the brain: the presence of at least two functional groups with metal-binding ability is suggested, and the formed chelation ring should have five or six members. Truly, monodentate ligands and those forming chelating rings of a different size to 5 or 6 can also coordinate metal ions, but the resulting complexes are generally too weak to allow these ligands to affect metal speciation in vivo. Coordinating functional groups can be negatively charged (or partially charged) oxygens such as carboxylates, phenolates, *N*-oxides, as well as nitrogen and sulphur atoms with non-delocalized lone pairs such as amines and thio-derivatives. For example, [l]{.smallcaps}-Dopa (chemical structure drawn in [Table S1](#app1-biomolecules-09-00269){ref-type="app"}) has two possible binding sites, one given by the two phenolic oxygens (catechol-like), and the other by the amino-acidic tail (glycine-like). Both binding sites, upon chelation, form a five membered ring with the metal ion. Some simple metal-chelating moieties often contained in CAs are depicted in [Figure 1](#biomolecules-09-00269-f001){ref-type="fig"}

The formation of stable metal--ligand complexes is more difficult to predict for peptides, because their metal chelation ability is strongly influenced by their spatial configuration. Also, it is not possible to assess the metal--ligand speciation of molecules bearing many chelating functional groups. Molecules of this kind, cited in [Table S1](#app1-biomolecules-09-00269){ref-type="app"}, were not reported in [Table 2](#biomolecules-09-00269-t002){ref-type="table"}. For the relevant metal ions (Cu(II), Cu(I), Fe(III), Fe(II), Mn(II), and Zn(II)) and for the compounds listed in [Table 2](#biomolecules-09-00269-t002){ref-type="table"}, the metal--ligand speciation will be given.

4. The Measurement of the Stability of Metal--Ligand Complexes {#sec4-biomolecules-09-00269}
==============================================================

While no ambiguities exist for reporting the stoichiometries of the complexes, it is worth describing all possible amounts used in literature to measure the stability of metal--ligand complexes: cumulative stability constants, stepwise stability constants, conditional stability constants, cologarithm of the concentration of free metal ion at equilibrium (pM), association constants, and dissociation constants.

Cumulative (or overall) stability constants are generally indicated with the Greek letter *β*. Each complex forming in solution is characterized by a *β* value. If M is the metal ion, H the proton, and L the ligand, and M*~m~*H*~h~*L*~l~* is the complex formed, *β* is defined as:$$\beta = \frac{\lbrack M_{m}H_{h}L_{l}\rbrack}{{\lbrack M\rbrack}^{m}{\lbrack H\rbrack}^{h}{\lbrack L\rbrack}^{l}}$$ where square brackets denote concentrations at equilibrium. The use of concentration amounts instead of activities (i.e., concentrations multiplied by activity coefficients) is generally allowed by maintaining a constant ionic strength during the experimental measurements. The (at least formal) presence of activities in equation (2) justifies why *β* values are commonly indicated without a measuring unit. Cumulative constants are usually given as logarithm (log*β*), and their knowledge is required for performing metal--ligand speciation calculations. Their experimental determination is however complicated as many experimental details have to be considered in order to obtain accurate results \[[@B312-biomolecules-09-00269],[@B313-biomolecules-09-00269]\]. In addition, *β* values do not allow to state the effective complex stability, which is also affected by the acid---base properties of metal ion and ligand, by the total metal (*c*~M~) and ligand (*c*~L~) concentrations, and by the pH. In other words, log*β* values by themselves are not informative and cannot be used to compare the stability of complexes formed by different metal ions and ligands.

Stepwise stability constants are generally indicated with the letter *K* and they are written as log*K*. Stepwise constants are more commonly employed if the complexes existing in solution contain one metal ion and one or more ligands (ML*~l~*, with *l* ≥ 1). For example, for the complex ML*~l~*, *K* can be defined as:$$K = \frac{\lbrack ML_{l}\rbrack}{\lbrack ML_{l - 1}\rbrack\lbrack L\rbrack}$$

Stepwise constants are related with cumulative ones, so that the former can be computed from the latter and vice versa--- e.g., for the complexes ML and ML~2~, log*β*~ML~ = log*K*~ML~ and log*β*~ML~2~~ = log*K*~ML~ + log*K*~ML~2~~, respectively.

Conditional (or effective) stability constants may be cumulative or stepwise and are indicated with the apostrophe (*β* ' or *K* '). For example, the conditional cumulative constant of the complex ML~2~ is defined as:$$\beta\prime = \frac{\lbrack ML_{2}\rbrack}{\sum{\lbrack M\prime\rbrack({\sum{\lbrack L\prime\rbrack)}^{2}}}}$$ where Σ\[M′\] and Σ\[L′\] represent the sum of the concentrations of uncomplexed metal ion and uncomplexed ligand at equilibrium, i.e., \[M\] + \[M(OH)\] + \[M(OH)~2~\] + ... and \[L\] + \[HL\] + \[H~2~L\] + ..., respectively. As Σ\[M′\] and Σ\[L′\] depend on pH, also log*β*′ and log*K*′ values depend on pH. These constants represent the effective stability of the given complexes in the presence of acid---base equilibria, so that they can be used to compare the stability of complexes formed by different metal ions and ligands. However, the comparison is possible only if the complexes have the same stoichiometries.

The other three amounts used to measure metal--ligand affinities, i.e., pM, association constants, and dissociation constants, differ from log*β*, log*K*, and from their conditional values, because only one number is given to characterize a solution containing the given metal and ligand. This is particularly useful when many complexes are formed and, in overall, one value resumes their strength.

pM represents the cologarithm of the concentration of free metal ion at equilibrium (pM = --log\[M\]), and it can be calculated if log *β* or log*K* values are known. The larger is pM, i.e., the lower is \[M\], the stronger are the complexes; pM can be used to compare the relative strength of the complexes, irrespective of their number and their stoichiometry. As pM depends on pH and also on *c*~M~ and *c*~L~, calculation must be performed under the same conditions: usually the pM value for MCT relevant conditions is computed at pH = 7.4, *c*~M~ = 10^−6^ mol/L and *c*~L~ = 10^−5^ mol/L \[[@B24-biomolecules-09-00269],[@B70-biomolecules-09-00269],[@B314-biomolecules-09-00269]\]. The only (but important) disadvantage of pM is that it can be computed if log*β* or log*K* values are known, i.e., the experimental procedure required to gain a pM value remains complicated.

Association constants, indicated as *K*~a~, are defined like *β* or *K* if only one complex ML forms in solution and no acid--base equilibria coexist:$$K_{a} = \frac{\lbrack ML\rbrack}{\lbrack M\rbrack\lbrack L\rbrack}$$

If M and/or L undergo acid--base equilibria, *K*~a~ for the complex ML is defined like *K*′ or *β*′. When more complexes of general stoichiometry M*~m~*H*~h~*L*~l~* coexist in solution, more *K*′ or *β*′ are needed, whereas still only one *K*~a~ suffices and is defined as:$$K_{a} = \frac{\sum{\lbrack M_{m}H_{h}L_{l}\rbrack}}{\sum{\lbrack M\prime\rbrack{\sum{\lbrack L\prime\rbrack}}}}$$ where Σ\[M*~m~*H*~h~*L*~l~*\] represents the sum of the concentrations of all complexes existing in solution. As *K*~a~ values are not thermodynamically defined, i.e., concentration values are employed instead of activities, they bear a measuring unit, which according to equation (6) is L/mol (or, more commonly, a multiple).

The dissociation constant, indicated as *K*~d~, is the inverse of *K*~a~ (measuring unit of *K*~d~: mol/L or a multiple). For example, if complexes of general stoichiometry M*~m~*H*~h~*L*~l~* coexist in solution, *K*~d~ can be defined as:$$K_{d} = \frac{\sum{\lbrack M\prime\rbrack{\sum{\lbrack L\prime\rbrack}}}}{\sum{\lbrack M_{m}H_{h}L_{l}\rbrack}}$$

Kiss et al. \[[@B102-biomolecules-09-00269]\] reported a similar definition of *K*~d~, where \[M\] was used instead of Σ\[M'\]. However, as the proton content is experimentally not controlled when *K*~d~ values are measured, not only for the ligand but also for the metal ion, we think that Equation (7) allows a more rigorous calculation of *K*~d~ values. Literature appears to have preference for measuring and reporting *K*~d~ more than *K*~a~ \[[@B313-biomolecules-09-00269],[@B315-biomolecules-09-00269]\]. This is probably due to the chemical usefulness and significance of *K*~d~, as it represents the concentration of free metal ion at which the concentrations of free ligand and of the complexes are equivalent \[[@B313-biomolecules-09-00269]\]. In the following, *K*~d~ values will be considered instead of *K*~a~ ones.

Values of *K*~d~ can be determined with a much simpler experimental design than that used to obtain log*β*, log*K* and pM \[[@B313-biomolecules-09-00269],[@B315-biomolecules-09-00269]\]. This is a crucial advantage when complicated ligands are studied, such as proteins, for which the determination of log*β* or log*K* is practically impossible. Still, *K*~d~ can be computed from Equation (7) if log*β* or log*K* values are available, so that the concentrations of all species existing in solution can be calculated. Therefore, *K*~d~ represents a simple tool and practically the only way to compare metal--ligand and metal--protein complex stabilities each other.

The main disadvantage of *K*~d~ is that it depends not only on pH, *c*~M~ and *c*~L~, but also on the copresence of other ligands or other metal ions \[[@B316-biomolecules-09-00269]\], as these affect Σ\[M′\] and Σ\[L′\] in Equation (7) (the same applies for *K*~a~ in equation 6, too). This explains at least in part why reported *K*~d~ values are scarcely reproducible (see [Table 1](#biomolecules-09-00269-t001){ref-type="table"}) and depend on the experimental conditions \[[@B12-biomolecules-09-00269]\]. Equations to correct *K*~d~ values, by taking into account the effect of a competing ligand (e.g., the buffer) and of the different pH, have been proposed \[[@B316-biomolecules-09-00269]\]. Standardized conditions to measure the *K*~d~ of metal--protein complexes are also being proposed \[[@B317-biomolecules-09-00269],[@B318-biomolecules-09-00269],[@B319-biomolecules-09-00269]\], and this should lead to more reproducible results, thus eventually allowing a more reliable comparison among *K*~d~ numbers.

5. The Metal--Ligand Speciation of Anti-Parkinson Drugs {#sec5-biomolecules-09-00269}
=======================================================

[Table S2 (Supplementary Materials)](#app1-biomolecules-09-00269){ref-type="app"} reports the metal--ligand speciation available in the literature for the ligands listed in [Table 2](#biomolecules-09-00269-t002){ref-type="table"} (rows) and the relevant metal ions, i.e., Cu(II), Cu(I), Fe(III), Fe(II), Mn(II), and Zn(II) (columns). If not differently specified in the notes of [Table S2](#app1-biomolecules-09-00269){ref-type="app"}, speciation information (stoichiometries of the complexes, and stability constants given as log*β*) has been obtained from the IUPAC stability constant database \[[@B320-biomolecules-09-00269]\].

The ionic product of water, the stability constants of the metal ion hydrolysis products, and the acidity constants of each ligand, have to be considered to complete the speciation picture and allow speciation calculations. The ionic product of water and the stability constants for hydrolysis products of the considered metal ions are resumed in [Table S3 in the Supplementary Materials](#app1-biomolecules-09-00269){ref-type="app"} (it is worth noting that these values are only sometimes reported in papers dealing with metal speciation). The acidity constants of the ligands listed in [Table 2](#biomolecules-09-00269-t002){ref-type="table"} have also been taken from the IUPAC stability constant database \[[@B320-biomolecules-09-00269]\] or from the papers reported in the notes, and they are given as log*β* values in [Table S2](#app1-biomolecules-09-00269){ref-type="app"} (column marked 'H^+^').

For some metal--ligand complexes, and for many ligand acidity constants, more than one speciation set has been reported in literature, and/or different log*β* values were proposed. For example, 27 different speciation models have been obtained for the Cu(II)/L-Dopa complexes \[[@B320-biomolecules-09-00269]\] In [Table S2](#app1-biomolecules-09-00269){ref-type="app"} only one speciation set has been reported, obtained at ionic strength and temperature as close as possible to 0.1 mol/L and 25 °C, respectively. This ionic strength represents a reasonable physiological environment; as regards temperature, 37 °C would better resemble physiological conditions, but speciation data at this temperature are few. For comparison purposes, we preferentially reported data at the most studied temperature of 25 °C. Notes were added in [Table S2](#app1-biomolecules-09-00269){ref-type="app"} if the studied temperature and ionic strength were different than 25 °C and 0.1 mol/L, respectively.

For many other ligands listed in [Table 2](#biomolecules-09-00269-t002){ref-type="table"}, no metal speciation set, and sometimes also no acidity constants, were available. This can be ascribed to several reasons, which for some CAs include their very recent development or proposal. For example, 3-(7-Amino-5-(cyclohexylamino)-\[1,2,4\]triazolo\[1,5-*a*\]\[1,3,5\]triazin-2-yl)-2-cyanoacrylamide, Aromadendrin, Astilbin, and many other CAs listed in [Table 2](#biomolecules-09-00269-t002){ref-type="table"} have been proposed for MCT in PD only approximately (or less than) one year ago. Possibly, the absence of equilibrium constants can also be justified by the above-mentioned experimental difficulties associated to accurate speciation measurements, which for complicated and often poorly water-soluble molecules may become formidable. Nevertheless, it is possible to tentatively predict the metal speciation of such ligands, by individuating the chelating moiety which is responsible for the complex formation (see also [Figure 1](#biomolecules-09-00269-f001){ref-type="fig"}), and by considering a simpler ligand having a known metal speciation and bearing the same moiety: ligands having the same chelating functional groups are expected to have a similar metal speciation. For example, complicated molecules bearing a 1,2-diaminoethane chelating group have been considered to have the same metal speciation as 1,2-diaminoethane itself. This predicted speciation should be employed with caution, because inductive and steric effects (and especially resonance ones, if existing) of the remaining part of the molecule might significantly modify the speciation picture. However, these estimations should represent the most reliable values available, until dedicated experimental measurements will be performed. Whenever this kind of assignation has been done, the reported metal-speciation has been marked as "tentative" in the notes of [Table S2](#app1-biomolecules-09-00269){ref-type="app"}. A speciation prediction has also been attempted for molecules bearing two or a maximum of three chelating moieties, by considering their speciation to be similar to that of a simpler ligand bearing the moiety forming the most stable complexes. In these cases, however, the inaccuracy of the predicted speciation might be relatively large.

[Table 3](#biomolecules-09-00269-t003){ref-type="table"} reports selected speciation information regarding Cu(II) which has been computed from the data of [Tables S2 and S3](#app1-biomolecules-09-00269){ref-type="app"}. Only the ligands for which a Cu(II) speciation was available or has been tentatively estimated were reported in [Table 3](#biomolecules-09-00269-t003){ref-type="table"}. Calculations have been performed by the software PITMAT (see \[[@B70-biomolecules-09-00269]\] and references therein). The first reported value is that of pM (pCu(II) = --log\[Cu(II)\], which has been computed at pH = 7.4, at *c*~M~ = 10^−6^ mol/L and at *c*~L~ = 10^−5^ mol/L, as recommended in MCT modeling \[[@B70-biomolecules-09-00269],[@B314-biomolecules-09-00269]\]. Besides pM, *K*~d~ also was computed according to Equation (7). To the best of our knowledge, no reference pH, *c*~M~ and *c*~L~ values have been hitherto adopted for the calculation of *K*~d~. We propose here that this calculation should be performed at the same conditions as for pM: pH = 7.4, *c*~M~ = 10^−6^ mol/L, and *c*~L~ = 10^−5^ mol/L. The last column of [Table 3](#biomolecules-09-00269-t003){ref-type="table"} reports the most abundant metal complex existing for each ligand at these same physiologically relevant conditions; if available, the charge of this complex is reported as well. [Table 4](#biomolecules-09-00269-t004){ref-type="table"}, [Table 5](#biomolecules-09-00269-t005){ref-type="table"}, [Table 6](#biomolecules-09-00269-t006){ref-type="table"}, [Table 7](#biomolecules-09-00269-t007){ref-type="table"}, [Table 8](#biomolecules-09-00269-t008){ref-type="table"} report the same information computed for Cu(I) ([Table 4](#biomolecules-09-00269-t004){ref-type="table"}), Fe(III) ([Table 5](#biomolecules-09-00269-t005){ref-type="table"}), Fe(II) ([Table 6](#biomolecules-09-00269-t006){ref-type="table"}), Mn(II) ([Table 7](#biomolecules-09-00269-t007){ref-type="table"}), and Zn(II) ([Table 8](#biomolecules-09-00269-t008){ref-type="table"}).

6. Possible Usages of Speciation Data for Metal Chelation Therapy against Parkinson's Disease {#sec6-biomolecules-09-00269}
=============================================================================================

Speciation calculations allow to predict which metal and ligand species exist in solution at a given pH and metal and ligand total concentrations. A speciation model can therefore be obtained: this was done for the calculations performed in [Table 3](#biomolecules-09-00269-t003){ref-type="table"}, [Table 4](#biomolecules-09-00269-t004){ref-type="table"}, [Table 5](#biomolecules-09-00269-t005){ref-type="table"}, [Table 6](#biomolecules-09-00269-t006){ref-type="table"}, [Table 7](#biomolecules-09-00269-t007){ref-type="table"} and [Table 8](#biomolecules-09-00269-t008){ref-type="table"}, where only some information has been given.

As anticipated, values of pM and *K*~d~ are useful to compare the relative strength of the complexes formed by different ligands with the same metal ion, or, conversely, by different metal ions with the same ligand. For example, the complexes formed by Fe(III) with 3-hydroxy-4(1H)-pyridinone (Deferiprone) have larger pM and lower *K*~d~ values than those formed with Luteolin, thus Fe(III)-Deferiprone complexes are stronger than Fe(III)-Luteolin ones. The values of pFe(III) for Deferiprone (19.3) or for Desferrioxamine (26.8) are often considered as milestones when new CAs are proposed for the chelation therapy of Fe overload \[[@B314-biomolecules-09-00269]\]: new compounds are considered to be effective enough if their pFe(III) is larger than that of Deferiprone or of Desferrioxamine.

More importantly, *K*~d~ values can be compared with those reported in [Table 1](#biomolecules-09-00269-t001){ref-type="table"}, allowing the assessment of whether a given ligand is able to remove a metal ion from α-syn: removal can occur if the *K*~d~ value is lower than that of α-syn. This approach has been proposed for MCT in Alzheimer's disease, where *K*~d~ values of the CA + metal ion complexes were recommended to be 10--100 times lower than *K*~d~ values of the amyloid β protein + metal ion ones \[[@B316-biomolecules-09-00269]\]. If the same approach is adopted for PD, it can be, e.g., deduced that Desferrioxamine (*K*~d~ = 1.81 × 10^−7^) is able to remove Fe(III) from α-syn (*K*~d~ = 10^−4^), and L-Dopa (*K*~d~ = 7.95 × 10^−6^) is able to remove Cu(II) from α-syn (*K*~d~ = 10^2^). Many other ligands, including L-Dopa (*K*~d~ = 2.96 × 10^4^), cannot remove Fe(III) from α-syn. However, it is necessary to underline that the *K*~d~ values reported in [Table 1](#biomolecules-09-00269-t001){ref-type="table"} are not completely reliable (the same also applies for *K*~d~ values of amyloid β protein + metal ion \[[@B12-biomolecules-09-00269]\]), for the reasons stated above, so this approach does not (still) allow drawing definite conclusions about the removal of the relevant metal ion from proteins. On the other hand, the control of metal ion dyshomeostasis in PD requires that the CAs do not form too strong metal complexes to avoid metal anemia and allow metal redeployment to other compartments, according to the conservative chelation strategy. Too high or too low *K*~d~ values are thus not suitable. Unfortunately, the limiting *K*~d~ values which an ideal CA should possess to be employed for the PD therapy are not known.

The information regarding the most abundant complex existing at physiological conditions can be useful for two reasons. The identity of the existing complexes (and in particular of the most abundant one) and their charge are crucial in determining their redistribution once the target metal ion has been complexed by the CA. For example, a charged complex is expected to be hydrophilic, thus being unable to pass cellular barriers and preferring to be solubilised in aqueous solutions (e.g., in the blood), whereas neutral species should behave in an opposite way. The structure of the complexes, which might be deduced from the stoichiometry, also has a main role in determining their properties and toxicity \[[@B321-biomolecules-09-00269]\].

As regards Fe and Cu, it is necessary to consider that they can undergo redox reactions even when complexed by a ligand. These reactions might be as harmful as or even more dangerous than those caused by the target metal ion at pathological in vivo conditions. The redox-induced toxicity of Fe and Cu complexes formed by several ligands is well known, so it has been used to develop new anti-cancer drugs \[[@B322-biomolecules-09-00269]\], but it appears to have been generally overlooked when MCT is employed for PD. The redox activity of Fe and Cu complexes depends on the relative stability of the complexes formed by the ions at the two oxidation states. As regards Fe, if a ligand L forms the complexes Fe^III^L and Fe^II^L with Fe(III) and Fe(II), respectively, a redox half-reaction can occur:

By means of simple substitutions in the Nernst equation of Fe(III)/Fe(II), the standard reduction potential of (8) can be computed:$$E_{Fe^{III}L/Fe^{II}L}^{0} = E^{0}{}_{Fe{({III})}/Fe{({II})}} + \frac{RT}{F}\mathit{\ln}\frac{\beta_{Fe^{II}L}}{\beta_{Fe^{III}L}}$$ where *E*^0^~Fe(III)/Fe(II)~ is the standard reduction potential for free Fe (0.771 V), and *β*~Fe^III^L~ and *β*~Fe^II^L~ are the cumulative stability constants of Fe^III^L and Fe^II^L, respectively. Values of *E*^0^ of any Fe or Cu complexes can be derived in a similar way if metal--ligand speciation at both oxidation states is known. Alternatively, electrochemical values can experimentally be obtained from voltammetric measurements (see, e.g., \[[@B323-biomolecules-09-00269]\]). The standard reduction potentials of Fe complexes might have an important role in determining whether they can undergo harmful redox cycling in vivo, as extensively descrived by Merkofer et al. \[[@B324-biomolecules-09-00269]\] and recently reviewed by Koppenol and Hider \[[@B325-biomolecules-09-00269]\]: in general, it appears that negative *E*^0^ values can guarantee the absence of such toxic phenomena. However, further work is necessary to evaluate limiting Fe and Cu *E*^0^ values under which no redox damage occurs in PD brains.

Other possible information which can be gathered from speciation calculations, even if focused on the bloodstream, has recently been reviewed by Kiss et al. \[[@B326-biomolecules-09-00269],[@B327-biomolecules-09-00269]\].

7. Concluding Remarks {#sec7-biomolecules-09-00269}
=====================

The development of drugs able to target several pathological pathways appears to be the best approach for PD therapy and of other important NDs such as Alzheimer's disease and Amyotrophic Lateral Sclerosis. Compounds which form complexes with the PD relevant metal ions, i.e., Cu(II), Cu(I), Fe(III), Fe(II), Mn(II) and Zn(II), are aimed to target metal dyshomeostasis. For these CAs and for these metal ions, the knowledge of metal--ligand speciation is of primary importance to predict the efficacy of the CA, its ability to remove dysregulated metal ions from toxic storages such as the α-syn complex and redeploy metal ions to safe stores (conservative chelation), the possible toxic effects induced by the metal complexes formed in PD brain, and in general to be able to model the distribution of the metal--ligand species in vivo. Still much work has to be performed to define the upper and the lower limiting metal *K*~d~ values required by a CA to disrupt the α-syn complex without causing excessive metal removal, as well as the suitable standard reduction potentials required by the complexes to avoid harmful redox cycling in the brain. Also, available speciation information is in part lacking, especially as regards Cu(I), for which very few stability constants values have been hitherto determined (possible strategies for effective studies of Cu(I) speciations have been proposed \[[@B328-biomolecules-09-00269]\]), but also for other metal ions and for several complicated or recently proposed CAs. If a complete metal--ligand speciation study (aimed to determine stability constants) cannot be performed, a *K*~d~ value should at least be determined. This amount represents a key number which can be used to compare simple metal--ligand complexes, for which the full speciation picture is available, with complicated ones like those involving α-syn, for which this information cannot be obtained. However, standardized experimental procedures are recommended to allow *K*~d~ values to be more rigorously and reliably compared with each other.
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The following are available online at <https://www.mdpi.com/2218-273X/9/7/269/s1>. Keywords and boolean logics used to perform the bibliographic search of this review. Table S1: Compounds used, tested or proposed for the therapy against Parkinson's disease, as obtained from a Literature survey in the year range 2014--2019 (April). Table S2: Acid---base and metal chelation properties of the compounds listed in [Table 2](#biomolecules-09-00269-t002){ref-type="table"}. Table S3: Ionic product of water and stability constants for hydrolysis products of Cu(II), Cu(I), Fe(III), Fe(II), Mn(II), and Zn(II).
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Simple metal-chelating moieties (listed in alphabetical order) which are often encountered in molecules used or proposed for the metal chelation therapy in Parkinson's disease.
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biomolecules-09-00269-t001_Table 1

###### 

Dissociation constants (*K*~d~) obtained at physiological pH for the complexes formed between metal ions and α-synuclein (values computed for the highest affinity binding site), and references (reviews).

  Metal Ion   *K*~d~ (nmol/L)    References
  ----------- ------------------ ---------------------------------------------------------------
  Cu(II)      10^2^              \[[@B12-biomolecules-09-00269],[@B61-biomolecules-09-00269]\]
  Cu(I)       10^4^--10^3^       \[[@B61-biomolecules-09-00269]\]
  Fe(III)     10^−4^             \[[@B12-biomolecules-09-00269],[@B60-biomolecules-09-00269]\]
  Fe(II)      10^6^--5 × 10^4^   \[[@B12-biomolecules-09-00269],[@B60-biomolecules-09-00269]\]
  Mn(II)      10^6^              \[[@B60-biomolecules-09-00269]\]
  Zn(II)      \>10^6^            \[[@B61-biomolecules-09-00269]\]

biomolecules-09-00269-t002_Table 2

###### 

Compounds displaying metal-chelation properties which have been used, tested or proposed for the therapy against PD, as obtained from a literature survey in the year range 2014--2019 (April). Substances are listed in the first column according to their alphabetical order. Only the latest and/or the most important references (e.g., reviews) are given in the last column. This Table is a subset of [Table S1](#app1-biomolecules-09-00269){ref-type="app"}, which also includes non-chelating compounds and compounds with non-predictable metal--ligand speciation. The chemical structure of each substance is reported in [Table S1](#app1-biomolecules-09-00269){ref-type="app"}.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound Name(s)                                                                                                References
  --------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------
  7DH                                                                                                             \[[@B112-biomolecules-09-00269]\]

  7MH                                                                                                             \[[@B112-biomolecules-09-00269]\]

  8A                                                                                                              \[[@B89-biomolecules-09-00269]\]

  8B                                                                                                              \[[@B89-biomolecules-09-00269]\]

  8C                                                                                                              \[[@B89-biomolecules-09-00269]\]

  8E                                                                                                              \[[@B89-biomolecules-09-00269]\]

  8F                                                                                                              \[[@B89-biomolecules-09-00269]\]

  *N*-Acetylcysteine                                                                                              \[[@B113-biomolecules-09-00269],[@B114-biomolecules-09-00269]\]

  ACPT-I                                                                                                          \[[@B115-biomolecules-09-00269]\]

  ADX88178                                                                                                        \[[@B116-biomolecules-09-00269]\]

  Alaternin                                                                                                       \[[@B117-biomolecules-09-00269]\]

  Alvespimycin                                                                                                    \[[@B118-biomolecules-09-00269]\]

  AM-251                                                                                                          \[[@B119-biomolecules-09-00269],[@B120-biomolecules-09-00269]\]

  Ambroxol                                                                                                        \[[@B121-biomolecules-09-00269],[@B122-biomolecules-09-00269]\]

  3-(7-Amino-5-(cyclohexyl-amino)\                                                                                \[[@B123-biomolecules-09-00269]\]
  -\[1,2,4\]triazolo\[1,5-a\]\                                                                                    
  \[1,3,5\]triazin-2-yl)-2\                                                                                       
  -cyanoacrylamide                                                                                                

  Aminothiazoles derivatives as SUMOylation activators                                                            \[[@B124-biomolecules-09-00269]\]

  AMN082                                                                                                          \[[@B115-biomolecules-09-00269]\]

  Amodiaquine                                                                                                     \[[@B125-biomolecules-09-00269],[@B126-biomolecules-09-00269]\]

  Antagonist of the A(2A) adenosine receptor-derivative 49                                                        \[[@B127-biomolecules-09-00269]\]

  Apigenin                                                                                                        \[[@B128-biomolecules-09-00269],[@B129-biomolecules-09-00269],[@B130-biomolecules-09-00269],[@B131-biomolecules-09-00269]\]

  Apomorphine                                                                                                     \[[@B132-biomolecules-09-00269],[@B133-biomolecules-09-00269]\]

  [l]{.smallcaps}-Arginine                                                                                        \[[@B134-biomolecules-09-00269]\]

  Aromadendrin                                                                                                    \[[@B128-biomolecules-09-00269]\]

  Ascorbic acid                                                                                                   \[[@B135-biomolecules-09-00269],[@B136-biomolecules-09-00269]\]

  ASI-1                                                                                                           \[[@B12-biomolecules-09-00269]\]

  ASI-5                                                                                                           \[[@B12-biomolecules-09-00269]\]

  Astilbin                                                                                                        \[[@B137-biomolecules-09-00269]\]

  Azilsartan                                                                                                      \[[@B138-biomolecules-09-00269]\]

  Baicalein                                                                                                       \[[@B139-biomolecules-09-00269],[@B140-biomolecules-09-00269],[@B141-biomolecules-09-00269]\]

  Benserazide                                                                                                     \[[@B142-biomolecules-09-00269],[@B143-biomolecules-09-00269]\]

  7*H*-Benzo, perimidin-7-one derivatives (R6 = OH)                                                               \[[@B144-biomolecules-09-00269]\]

  4*H*-1-Benzopyran-4-one                                                                                         \[[@B145-biomolecules-09-00269]\]

  8-Benzyl-tetrahydropyrazino, purinedione derivatives (derivative n.57)                                          \[[@B146-biomolecules-09-00269]\]

  Bikaverin                                                                                                       \[[@B147-biomolecules-09-00269]\]

  (−)-*N*6-(2-(4-(Biphenyl-4-yl)\                                                                                 \[[@B148-biomolecules-09-00269]\]
  piperazin-1-yl)-ethyl)-*N*6-\                                                                                   
  propyl-4,5,6,7-tetrahydro-\                                                                                     
  benzo, thiazole-2,6-diamine derivatives                                                                         

  2.2'-Bipyridyl (2,2'-bipyridine)                                                                                \[[@B112-biomolecules-09-00269]\]

  4-((5-Bromo-3-chloro-2-\                                                                                        \[[@B149-biomolecules-09-00269],[@B150-biomolecules-09-00269]\]
  hydroxybenzyl) amino)-2-\                                                                                       
  hydroxybenzoic acid (LX007, ZL006)                                                                              

  C-3 (α carboxyfullerene)                                                                                        \[[@B151-biomolecules-09-00269]\]

  Caffeic acid amide analogues                                                                                    \[[@B152-biomolecules-09-00269],[@B153-biomolecules-09-00269],[@B154-biomolecules-09-00269],[@B155-biomolecules-09-00269]\]

  Carbazole-derived compounds                                                                                     \[[@B156-biomolecules-09-00269]\]

  Carbidopa                                                                                                       \[[@B135-biomolecules-09-00269],[@B157-biomolecules-09-00269]\]

  Carnosic acid                                                                                                   \[[@B154-biomolecules-09-00269],[@B158-biomolecules-09-00269]\]

  Catechin                                                                                                        \[[@B24-biomolecules-09-00269],[@B128-biomolecules-09-00269]\]

  Ceftriaxone                                                                                                     \[[@B12-biomolecules-09-00269],[@B159-biomolecules-09-00269],[@B160-biomolecules-09-00269],[@B161-biomolecules-09-00269]\]

  Celastrol                                                                                                       \[[@B162-biomolecules-09-00269],[@B163-biomolecules-09-00269]\]

  CEP-1347                                                                                                        \[[@B164-biomolecules-09-00269],[@B165-biomolecules-09-00269]\]

  Chebulagic acid                                                                                                 \[[@B166-biomolecules-09-00269]\]

  Chlorogenic acid                                                                                                \[[@B167-biomolecules-09-00269]\]

  3′-*O*-(3-Chloropivaloyl)\                                                                                      \[[@B168-biomolecules-09-00269]\]
  quercetin                                                                                                       

  Chlorpromazine                                                                                                  \[[@B108-biomolecules-09-00269]\]

  Chrysin                                                                                                         \[[@B128-biomolecules-09-00269],[@B169-biomolecules-09-00269],[@B170-biomolecules-09-00269]\]

  Clioquinol                                                                                                      \[[@B89-biomolecules-09-00269],[@B91-biomolecules-09-00269],[@B171-biomolecules-09-00269],[@B172-biomolecules-09-00269]\]

  Clioquinol-selegiline hybrid                                                                                    \[[@B79-biomolecules-09-00269]\]

  Clovamide analogues\                                                                                            \[[@B173-biomolecules-09-00269]\]
  (R1 and R2 = OH,\                                                                                               
  and/or R3 and R4 = OH)                                                                                          

  "Compound 1"                                                                                                    \[[@B174-biomolecules-09-00269]\]

  "Compound (−)-8a"                                                                                               \[[@B175-biomolecules-09-00269]\]

  "Compound 8"                                                                                                    \[[@B176-biomolecules-09-00269]\]

  "Compound 21", derivative of 3-methyl-1-(2,4,6-trihydroxy\                                                      \[[@B177-biomolecules-09-00269]\]
  phenyl) butan-1-one                                                                                             

  "Compound (−)-21a"\                                                                                             \[[@B178-biomolecules-09-00269]\]
  , derivative of *N*-6-(2-(4-(1*H*-indol-5-yl)\                                                                  
  piperazin-1-yl)ethyl)-*N*-6-\                                                                                   
  propyl-4,5,6,7-tetrahydro-\                                                                                     
  benzo\[*d*\]thiazole-2,6-diamine                                                                                

  Creatine                                                                                                        \[[@B179-biomolecules-09-00269],[@B180-biomolecules-09-00269]\]

  Cudraflavone B                                                                                                  \[[@B181-biomolecules-09-00269]\]

  Curcumin                                                                                                        \[[@B89-biomolecules-09-00269],[@B117-biomolecules-09-00269],[@B182-biomolecules-09-00269],[@B183-biomolecules-09-00269],[@B184-biomolecules-09-00269]\]

  Cyanidin                                                                                                        \[[@B185-biomolecules-09-00269],[@B186-biomolecules-09-00269]\]

  D-512                                                                                                           \[[@B187-biomolecules-09-00269]\]

  D-607 (bipyridyl-D2R/D3R agonist hybrid)                                                                        \[[@B12-biomolecules-09-00269],[@B188-biomolecules-09-00269],[@B189-biomolecules-09-00269]\]

  DA-2 (8D)                                                                                                       \[[@B12-biomolecules-09-00269],[@B89-biomolecules-09-00269]\]

  DA-3                                                                                                            \[[@B12-biomolecules-09-00269]\]

  DA-4                                                                                                            \[[@B12-biomolecules-09-00269]\]

  Dabigatran etexilate                                                                                            \[[@B190-biomolecules-09-00269]\]

  Dabrafenib                                                                                                      \[[@B191-biomolecules-09-00269]\]

  (*S*)-3,4-DCPG                                                                                                  \[[@B115-biomolecules-09-00269]\]

  Deferasirox                                                                                                     \[[@B24-biomolecules-09-00269]\]

  Deferricoprogen                                                                                                 \[[@B192-biomolecules-09-00269]\]

  Delphinidin                                                                                                     \[[@B160-biomolecules-09-00269],[@B185-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269]\]

  Demethoxycurcumin                                                                                               \[[@B195-biomolecules-09-00269]\]

  Dendropanax morbifera active compound                                                                           \[[@B196-biomolecules-09-00269]\]

  Desferrioxamine (Desferoxamine, Desferal, DFO)                                                                  \[[@B112-biomolecules-09-00269]\]

  (S)-*N*-(3-(3,6-Dibromo-9*H*\                                                                                   \[[@B197-biomolecules-09-00269]\]
  -carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine                                                        

  4,5-*O*-Dicaffeoyl-1-*O*-(malic acid methyl ester)-quinic acid derivatives (R1, R2, R3, R4, or R5 = caffeoyl)   \[[@B198-biomolecules-09-00269]\]

  Dihydromyricetin                                                                                                \[[@B199-biomolecules-09-00269]\]

  5-(3,4-Dihydroxybenzylidene) -2,2-dimethyl-1,3-dioxane-4,6-dione                                                \[[@B200-biomolecules-09-00269]\]

  7,8-Dihydroxycoumarin derivative DHC12                                                                          \[[@B79-biomolecules-09-00269]\]

  3′,4′-Dihydroxyflavone                                                                                          \[[@B201-biomolecules-09-00269]\]

  7,8-Dihydroxyflavone                                                                                            \[[@B202-biomolecules-09-00269],[@B203-biomolecules-09-00269]\]

  5,7-Dihydroxy-4′-methoxy\                                                                                       \[[@B204-biomolecules-09-00269]\]
  flavone                                                                                                         

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfones                                                                      \[[@B205-biomolecules-09-00269]\]

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfoxides                                                                    \[[@B205-biomolecules-09-00269]\]

  5,3'-Dihydroxy-3,7,4'\                                                                                          \[[@B206-biomolecules-09-00269]\]
  -trimethoxyflavone                                                                                              

  2-\[\[(1,1-Dimethylethyl) oxidoimino\]-methyl\]-3,5,6-\                                                         \[[@B207-biomolecules-09-00269]\]
  trimethylpyrazine                                                                                               

  DKP                                                                                                             \[[@B85-biomolecules-09-00269]\]

  L-DOPA (levodopa, CVT-301)                                                                                      \[[@B132-biomolecules-09-00269],[@B135-biomolecules-09-00269],[@B208-biomolecules-09-00269]\]

  DOPA-derived peptido-mimetics (deprotected)                                                                     \[[@B209-biomolecules-09-00269]\]

  DOPA-derived peptido-mimetics (protected)                                                                       \[[@B209-biomolecules-09-00269]\]

  L-DOPA deuterated (D3-L-DOPA)                                                                                   \[[@B210-biomolecules-09-00269]\]

  Doxycycline                                                                                                     \[[@B211-biomolecules-09-00269],[@B212-biomolecules-09-00269]\]

  Droxidopa                                                                                                       \[[@B110-biomolecules-09-00269]\]

  Echinacoside                                                                                                    \[[@B213-biomolecules-09-00269]\]

  Ellagic acid                                                                                                    \[[@B214-biomolecules-09-00269]\]

  Entacapone (Comtan, ASI-6)                                                                                      \[[@B12-biomolecules-09-00269],[@B215-biomolecules-09-00269],[@B216-biomolecules-09-00269]\]

  Enzastaurin                                                                                                     \[[@B164-biomolecules-09-00269]\]

  Epicatechin                                                                                                     \[[@B128-biomolecules-09-00269],[@B160-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269]\]

  Epigallocatechin-3-gallate                                                                                      \[[@B117-biomolecules-09-00269],[@B217-biomolecules-09-00269],[@B218-biomolecules-09-00269]\]

  Etidronate (HEDPA)                                                                                              \[[@B219-biomolecules-09-00269]\]

  Exifone                                                                                                         \[[@B12-biomolecules-09-00269]\]

  F13714                                                                                                          \[[@B220-biomolecules-09-00269]\]

  F15599                                                                                                          \[[@B220-biomolecules-09-00269],[@B221-biomolecules-09-00269]\]

  Farrerol                                                                                                        \[[@B222-biomolecules-09-00269]\]

  Fisetin (3,3′,4′,7-Tetrahydroxy\                                                                                \[[@B223-biomolecules-09-00269],[@B224-biomolecules-09-00269],[@B225-biomolecules-09-00269]\]
  flavone)                                                                                                        

  Fraxetin                                                                                                        \[[@B117-biomolecules-09-00269]\]

  Galangin                                                                                                        \[[@B226-biomolecules-09-00269]\]

  Gallic acid and derivatives                                                                                     \[[@B214-biomolecules-09-00269],[@B227-biomolecules-09-00269],[@B228-biomolecules-09-00269]\]

  Gallocatechin                                                                                                   \[[@B128-biomolecules-09-00269]\]

  Garcinol                                                                                                        \[[@B229-biomolecules-09-00269]\]

  Genistein                                                                                                       \[[@B117-biomolecules-09-00269],[@B128-biomolecules-09-00269],[@B230-biomolecules-09-00269],[@B231-biomolecules-09-00269]\]

  Glutamine                                                                                                       \[[@B232-biomolecules-09-00269]\]

  Glutathione derivatives                                                                                         \[[@B63-biomolecules-09-00269]\]

  Glutathione\                                                                                                    \[[@B233-biomolecules-09-00269]\]
  -hydroxyquinoline compound                                                                                      

  Glutathione-[l]{.smallcaps}-DOPA compound                                                                       \[[@B234-biomolecules-09-00269]\]

  Gly-N-C-DOPA                                                                                                    \[[@B209-biomolecules-09-00269]\]

  GSK2795039                                                                                                      \[[@B108-biomolecules-09-00269]\]

  Guanabenz                                                                                                       \[[@B235-biomolecules-09-00269]\]

  Hesperidin                                                                                                      \[[@B128-biomolecules-09-00269],[@B236-biomolecules-09-00269]\]

  Hinokitiol                                                                                                      \[[@B237-biomolecules-09-00269]\]

  8-HQ-MC-5 (VK-28)                                                                                               \[[@B12-biomolecules-09-00269],[@B24-biomolecules-09-00269],[@B89-biomolecules-09-00269],[@B92-biomolecules-09-00269],[@B93-biomolecules-09-00269]\]

  4-Hydroxyisophthalic acid                                                                                       \[[@B238-biomolecules-09-00269]\]

  1-Hydroxy-2-pyridinone derivatives                                                                              \[[@B89-biomolecules-09-00269],[@B239-biomolecules-09-00269]\]

  3-Hydroxy-4(1*H*)-pyridinone (Deferiprone)                                                                      \[[@B112-biomolecules-09-00269],[@B239-biomolecules-09-00269],[@B240-biomolecules-09-00269]\]

  8-Hydroxyquinoline                                                                                              \[[@B241-biomolecules-09-00269]\]

  8-Hydroxyquinoline-2-\                                                                                          \[[@B242-biomolecules-09-00269]\]
  carboxaldehyde isonicotinoyl hydrazone                                                                          

  Hydroxyquinoline-propargyl hybrid (HLA 20)                                                                      \[[@B12-biomolecules-09-00269],[@B79-biomolecules-09-00269],[@B89-biomolecules-09-00269]\]

  Hydroxytyrosol butyrate                                                                                         \[[@B243-biomolecules-09-00269]\]

  Hyperoside                                                                                                      \[[@B117-biomolecules-09-00269]\]

  IC87201                                                                                                         \[[@B150-biomolecules-09-00269]\]

  Icariin                                                                                                         \[[@B244-biomolecules-09-00269]\]

  Icariside II                                                                                                    \[[@B245-biomolecules-09-00269]\]

  l-(7-imino-3-propyl-2,3-\                                                                                       \[[@B246-biomolecules-09-00269]\]
  dihydrothiazolo \[4,5-*d*\]pyrimidin-6(7*H*)-yl)urea                                                            

  Imipramine                                                                                                      \[[@B247-biomolecules-09-00269]\]

  Isobavachalcone                                                                                                 \[[@B248-biomolecules-09-00269]\]

  Isochlorogenic acid                                                                                             \[[@B167-biomolecules-09-00269]\]

  Isoquercetin (Isoquercitrin)                                                                                    \[[@B249-biomolecules-09-00269]\]

  Kaempferol                                                                                                      \[[@B128-biomolecules-09-00269],[@B160-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269]\]

  Kaempferol, 3-*O*-a-[l]{.smallcaps} arabinofuranoside-7-*O*-a-[l]{.smallcaps}-rhamnopyranoside                  \[[@B214-biomolecules-09-00269]\]

  KR33493                                                                                                         \[[@B250-biomolecules-09-00269]\]

  Kukoamine                                                                                                       \[[@B251-biomolecules-09-00269]\]

  Lestaurtinib                                                                                                    \[[@B164-biomolecules-09-00269]\]

  Lipoic acid                                                                                                     \[[@B252-biomolecules-09-00269],[@B253-biomolecules-09-00269],[@B254-biomolecules-09-00269]\]

  Luteolin                                                                                                        \[[@B128-biomolecules-09-00269]\]

  LY354740                                                                                                        \[[@B115-biomolecules-09-00269]\]

  M10                                                                                                             \[[@B24-biomolecules-09-00269]\]

  M30 (VAR10303)                                                                                                  \[[@B112-biomolecules-09-00269],[@B255-biomolecules-09-00269]\]

  M99                                                                                                             \[[@B24-biomolecules-09-00269]\]

  Macranthoin G                                                                                                   \[[@B256-biomolecules-09-00269]\]

  Magnesium lithospermate B                                                                                       \[[@B257-biomolecules-09-00269]\]

  α-Mangostin                                                                                                     \[[@B258-biomolecules-09-00269]\]

  γ-Mangostin                                                                                                     \[[@B259-biomolecules-09-00269]\]

  MAOI-1                                                                                                          \[[@B12-biomolecules-09-00269]\]

  MAOI-2                                                                                                          \[[@B12-biomolecules-09-00269]\]

  MAOI-4                                                                                                          \[[@B12-biomolecules-09-00269]\]

  MAOI-8                                                                                                          \[[@B12-biomolecules-09-00269]\]

  Meclofenamic acid                                                                                               \[[@B260-biomolecules-09-00269]\]

  Metformin (Met)                                                                                                 \[[@B261-biomolecules-09-00269],[@B262-biomolecules-09-00269]\]

  Methoxy-6-acetyl-7-\                                                                                            \[[@B117-biomolecules-09-00269]\]
  methylijuglone                                                                                                  

  N'-(4-Methylbenzylidene)-5-phenylisoxazole-3-carbohydrazide                                                     \[[@B263-biomolecules-09-00269]\]

  Mildronate                                                                                                      \[[@B264-biomolecules-09-00269]\]

  Minocycline                                                                                                     \[[@B12-biomolecules-09-00269],[@B160-biomolecules-09-00269],[@B265-biomolecules-09-00269]\]

  Mitomycin C                                                                                                     \[[@B266-biomolecules-09-00269]\]

  MitoQ                                                                                                           \[[@B108-biomolecules-09-00269]\]

  Morin (3,5,7,29,49-pentahydroxy\                                                                                \[[@B160-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269],[@B267-biomolecules-09-00269]\]
  flavone)                                                                                                        

  \[18F\]MPPF                                                                                                     \[[@B107-biomolecules-09-00269]\]

  MSX-3                                                                                                           \[[@B268-biomolecules-09-00269]\]

  Myricetin                                                                                                       \[[@B128-biomolecules-09-00269],[@B269-biomolecules-09-00269],[@B270-biomolecules-09-00269]\]

  Myricitrin                                                                                                      \[[@B271-biomolecules-09-00269]\]

  Naringenin                                                                                                      \[[@B128-biomolecules-09-00269],[@B272-biomolecules-09-00269]\]

  Naringin                                                                                                        \[[@B117-biomolecules-09-00269],[@B273-biomolecules-09-00269],[@B274-biomolecules-09-00269]\]

  Nicotinamide adenine dinucleotide phosphate (NADPH)                                                             \[[@B275-biomolecules-09-00269],[@B276-biomolecules-09-00269]\]

  Nicotinamide mononucleotide                                                                                     \[[@B277-biomolecules-09-00269]\]

  Nitecapone                                                                                                      \[[@B278-biomolecules-09-00269]\]

  Nordihydroguaiaretic                                                                                            \[[@B160-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269]\]

  Oleuropein                                                                                                      \[[@B279-biomolecules-09-00269]\]

  Opicapone                                                                                                       \[[@B278-biomolecules-09-00269]\]

  P7C3                                                                                                            \[[@B280-biomolecules-09-00269],[@B281-biomolecules-09-00269]\]

  PBF-509                                                                                                         \[[@B282-biomolecules-09-00269]\]

  PBT2                                                                                                            \[[@B89-biomolecules-09-00269],[@B283-biomolecules-09-00269]\]

  PBT434                                                                                                          \[[@B284-biomolecules-09-00269]\]

  Petunidin                                                                                                       \[[@B185-biomolecules-09-00269]\]

  Phenothiazine 2Bc (n = 0 and n = 1)                                                                             \[[@B285-biomolecules-09-00269]\]

  Phenylhydroxamates                                                                                              \[[@B286-biomolecules-09-00269]\]

  Piceatannol                                                                                                     \[[@B160-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269]\]

  Pinostrobin                                                                                                     \[[@B287-biomolecules-09-00269]\]

  Piperazine-8-OH-quinolone hybrid                                                                                \[[@B79-biomolecules-09-00269]\]

  Preladenant                                                                                                     \[[@B282-biomolecules-09-00269],[@B288-biomolecules-09-00269]\]

  Promethazine                                                                                                    \[[@B289-biomolecules-09-00269]\]

  Protocatechuic acid                                                                                             \[[@B170-biomolecules-09-00269]\]

  Protosappanin A                                                                                                 \[[@B290-biomolecules-09-00269]\]

  Punicalangin                                                                                                    \[[@B270-biomolecules-09-00269],[@B291-biomolecules-09-00269]\]

  Pyrazolobenzothiazine-based carbothioamides                                                                     \[[@B292-biomolecules-09-00269]\]

  Pyridoxal isonicotinoyl hydrazone (PIH) and related compounds                                                   \[[@B24-biomolecules-09-00269],[@B89-biomolecules-09-00269]\]

  Pyrimidinone 8                                                                                                  \[[@B293-biomolecules-09-00269]\]

  Q1                                                                                                              \[[@B89-biomolecules-09-00269]\]

  Q4                                                                                                              \[[@B89-biomolecules-09-00269]\]

  Quercetin                                                                                                       \[[@B117-biomolecules-09-00269],[@B294-biomolecules-09-00269],[@B295-biomolecules-09-00269]\]

  Quinolines Derivatives as SUMOylation activators                                                                \[[@B124-biomolecules-09-00269]\]

  Radotinib                                                                                                       \[[@B296-biomolecules-09-00269]\]

  Riboflavin                                                                                                      \[[@B297-biomolecules-09-00269],[@B298-biomolecules-09-00269]\]

  Rifampicin (ASI-3)                                                                                              \[[@B12-biomolecules-09-00269],[@B160-biomolecules-09-00269]\]

  Rimonabant                                                                                                      \[[@B119-biomolecules-09-00269],[@B120-biomolecules-09-00269],[@B282-biomolecules-09-00269]\]

  Rosmarinic acid                                                                                                 \[[@B154-biomolecules-09-00269],[@B299-biomolecules-09-00269]\]

  Rotigotine                                                                                                      \[[@B105-biomolecules-09-00269],[@B133-biomolecules-09-00269],[@B278-biomolecules-09-00269],[@B300-biomolecules-09-00269]\]

  Rutin                                                                                                           \[[@B128-biomolecules-09-00269],[@B249-biomolecules-09-00269]\]

  Salicylate, sodium salt                                                                                         \[[@B301-biomolecules-09-00269]\]

  Salvianolic Acid B                                                                                              \[[@B117-biomolecules-09-00269]\]

  SCH-58261                                                                                                       \[[@B105-biomolecules-09-00269],[@B302-biomolecules-09-00269]\]

  SCH412348                                                                                                       \[[@B105-biomolecules-09-00269]\]

  Silibinin (silybin) A, B                                                                                        \[[@B89-biomolecules-09-00269]\]

  Silydianin                                                                                                      \[[@B24-biomolecules-09-00269]\]

  ST1535                                                                                                          \[[@B282-biomolecules-09-00269]\]

  ST4206                                                                                                          \[[@B282-biomolecules-09-00269]\]

  Staurosporine                                                                                                   \[[@B164-biomolecules-09-00269]\]

  Stemazole                                                                                                       \[[@B303-biomolecules-09-00269]\]

  Sulfuretin                                                                                                      \[[@B304-biomolecules-09-00269]\]

  Tannic acid                                                                                                     \[[@B160-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269]\]

  Tanshinol                                                                                                       \[[@B117-biomolecules-09-00269]\]

  Taurine                                                                                                         \[[@B305-biomolecules-09-00269]\]

  Taxifolin                                                                                                       \[[@B128-biomolecules-09-00269]\]

  Tectorigenin                                                                                                    \[[@B306-biomolecules-09-00269]\]

  Tetracycline                                                                                                    \[[@B307-biomolecules-09-00269]\]

  Tolcapone (ASI-7)                                                                                               \[[@B12-biomolecules-09-00269],[@B105-biomolecules-09-00269]\]

  Tozadenant                                                                                                      \[[@B282-biomolecules-09-00269],[@B302-biomolecules-09-00269]\]

  Transilitin                                                                                                     \[[@B270-biomolecules-09-00269]\]

  O-Trensox                                                                                                       \[[@B24-biomolecules-09-00269]\]

  2′,3′,4′-Trihydroxyflavone                                                                                      \[[@B270-biomolecules-09-00269]\]

  2,3,3-Trisphosphonate                                                                                           \[[@B219-biomolecules-09-00269]\]

  V81444                                                                                                          \[[@B282-biomolecules-09-00269]\]

  VAS3947                                                                                                         \[[@B108-biomolecules-09-00269]\]

  VAS2870                                                                                                         \[[@B108-biomolecules-09-00269]\]

  Verbascoside                                                                                                    \[[@B160-biomolecules-09-00269],[@B193-biomolecules-09-00269],[@B194-biomolecules-09-00269]\]

  WIN 55,212-2                                                                                                    \[[@B119-biomolecules-09-00269],[@B120-biomolecules-09-00269]\]

  WR-1065                                                                                                         \[[@B308-biomolecules-09-00269]\]

  Zonisamide                                                                                                      \[[@B309-biomolecules-09-00269],[@B310-biomolecules-09-00269],[@B311-biomolecules-09-00269]\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

pCu(II) and *K*~d~ values, and the most abundant Cu(II) complex, obtained at physiologically relevant conditions: pH = 7.4, *c*~Cu~ = 10^--6^ mol/L, and *c*~L~ = 10^--5^ mol/L. Computations have been performed from data of [Tables S2 and S3 (Supplementary Materials)](#app1-biomolecules-09-00269){ref-type="app"}. Refer to [Table S2](#app1-biomolecules-09-00269){ref-type="app"} to identify ligands for which only tentative speciations were proposed, and ligands whose complexes have unknown charges.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound Name(s)                                                                                                                  pCu(II)   *K*~d~ (nmol/L)   Most Abundant Complex
  --------------------------------------------------------------------------------------------------------------------------------- --------- ----------------- -----------------------
  7DH\                                                                                                                              14.2      5.91 × 10^−5^     CuL~2~
  7MH                                                                                                                                                           

  8A\                                                                                                                               14.2      5.91 × 10^−5^     CuL~2~
  8B\                                                                                                                                                           
  8C                                                                                                                                                            

  8E\                                                                                                                               10.6      2.35 × 10^−1^     CuL~2~
  8F                                                                                                                                                            

  *N*-Acetyl cysteine                                                                                                               6.2       3.82 × 10^4^      CuL

  ACPT-I                                                                                                                            7.3       5.93 × 10^2^      CuL

  ADX88178                                                                                                                          7.4       5.15 × 10^2^      CuL

  Alaternin                                                                                                                         16.5      3.39 × 10^−7^     CuL~2~

  Alvespimycin                                                                                                                      10.3      5.35 × 10^−1^     CuL~2~^2+^

  AM-251                                                                                                                            6.3       1.47 × 10^4^      CuL

  Ambroxol                                                                                                                          9.2       7.26              CuL^+^

  3-(7-Amino-5-(cyclohexylamino)-\[1,2,4\]triazolo\[1,5-*a*\]\[1,3,5\]\                                                             9.1       7.58              CuL~2~
  triazin-2-yl)-2-cyanoacrylamide                                                                                                                               

  Aminothiazoles derivatives as SUMOylation activators                                                                              9.7       1.86              CuL~2~

  AMN082                                                                                                                            10.3      5.35 × 10^−1^     CuL~2~^2+^

  Amodiaquine                                                                                                                       6.1       1.90 × 10^7^      CuHL

  Antagonist of the A(2A) adenosine receptor-derivative 49                                                                          6.4       9.65 × 10^3^      CuL

  Apigenin                                                                                                                          6.8       2.39 × 10^3^      CuH~2~L^+^

  Apomorphine                                                                                                                       7.4       5.06 × 10^2^      CuL

  [l]{.smallcaps}-Arginine                                                                                                          7.1       9.57 × 10^2^      CuL^2+^

  Aromadendrin                                                                                                                      11.1      8.29 × 10^−2^     CuL

  Ascorbic acid                                                                                                                     6.1       2.43 × 10^5^      Cu~2~H~--2~L~2~

  ASI-1                                                                                                                             7.9       1.21 × 10^2^      CuL~2~

  ASI-5                                                                                                                             6.1       2.23 × 10^6^      CuL

  Astilbin                                                                                                                          7.4       5.06 × 10^2^      CuL

  Azilsartan                                                                                                                        6.1       4.53 × 10^5^      CuL

  Baicalein                                                                                                                         9.3       5.41              CuL~2~^2−^

  Benserazide                                                                                                                       9.3       5.30              CuL~2~

  7*H*-benzo\[e\] perimidin-7-one derivatives                                                                                       14        1.05 × 10^−4^     CuL~2~

  8-Benzyl-tetrahydropyrazino\[2,1-*f*\]purinedione (derivative n. 57)                                                              6.1       3.36 × 10^6^      CuL

  Bikaverin                                                                                                                         14        1.05 × 10^−4^     CuL~2~

  (−)-*N*6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-*N*6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]thiazole-2,6-diamine derivatives   10.3      5.35 × 10^−1^     CuL~2~^2+^

  2,2′-bipyridyl                                                                                                                    10.6      2.35 × 10^−1^     CuL~2~^2+^

  4-((5-bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic acid (LX007, ZL006)                                                 6.2       6.51 × 10^4^      CuL

  C-3 (α-carboxyfullerene)                                                                                                          6.9       1.96 × 10^3^      CuL

  Caffeic acid amide analogues                                                                                                      7.3       6.02 × 10^2^      CuH~−1~L

  Carbazole-derived compounds                                                                                                       10.3      5.35 × 10^−1^     CuL~2~^2+^

  Carbidopa                                                                                                                         15.1      8.11 × 10^−6^     CuH~−2~L

  Carnosic acid                                                                                                                     7.4       5.06 × 10^2^      CuL

  Catechin                                                                                                                          7.9       1.50 × 10^2^      CuH~2~L

  Ceftriaxone                                                                                                                       6.1       4.04 × 10^6^      CuL

  Celastrol                                                                                                                         6.5       5.27 × 10^3^      CuL

  Chebulagic acid                                                                                                                   6.3       1.51 × 10^4^      CuHL

  Chlorogenic acid                                                                                                                  8.3       5.04 × 10^1^      CuL^−^

  3′-*O*-(3-chloropivaloyl) quercetin                                                                                               11.1      8.29 × 10^−2^     CuL

  Chlorpromazine                                                                                                                    6.3       1.47 × 10^4^      CuL^2+^

  Chrysin                                                                                                                           10.6      2.97 × 10^−1^     CuHL^+^

  Clioquinol                                                                                                                        14.2      5.91 × 10^−5^     CuL~2~

  Clovamide analogues (R~1~ and R~2~ = OH, and/or R~3~ and R~4~ = OH)                                                               7.4       5.06 × 10^2^      CuL

  "Compound 1"                                                                                                                      10.3      5.35 × 10^−1^     CuL~2~^2+^

  "Compound 8"                                                                                                                      6.1       4.37 × 10^5^      CuL~2~

  "Compound 21", derivative of\                                                                                                     7.3       5.93 × 10^2^      CuL^+^
  3-methyl-1-(2,4,6-trihydroxyphenyl) butan-1-one                                                                                                               

  "Compound (−)-21a", derivative of *N*-6-(2-(4-(1*H*-indol-5-yl)\                                                                  10.3      5.35 × 10^−1^     CuL~2~^3+^
  piperazin-1-yl)ethyl)-*N*-6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]\                                                                                            
  thiazole-2,6-diamine                                                                                                                                          

  Creatine                                                                                                                          6.8       2.26 × 10^3^      CuH~−1~L

  Cudraflavone B                                                                                                                    11.1      8.29 × 10^−2^     CuL

  Curcumin                                                                                                                          7.9       1.21 × 10^2^      CuL~2~

  Cyanidin                                                                                                                          7.4       5.06 × 10^2^      CuL

  D512                                                                                                                              10.3      5.35 × 10^−1^     CuL~2~^2+^

  D607 (bipyridyl-D2R/D3R agonist hybrid)                                                                                           10.6      2.35 × 10^−1^     CuL~2~

  DA-2 (8D)                                                                                                                         14.2      5.91 × 10^−5^     CuL~2~

  DA-3                                                                                                                              10.3      5.35 × 10^−1^     CuL~2~

  DA-4                                                                                                                              10.3      5.35 × 10^−1^     CuL~2~

  Dabigatran etexilate                                                                                                              10.3      5.35 × 10^−1^     CuL~2~

  Dabrafenib                                                                                                                        6.1       3.36 × 10^6^      CuL

  (*S*)-3-4-DCPG                                                                                                                    6.1       4.54 × 10^5^      CuL

  Deferricoprogen                                                                                                                   12.6      3.17 × 10^−3^     CuHL

  Delphinidin                                                                                                                       9.3       5.30              CuL~2~

  Demethoxycurcumin                                                                                                                 7.9       1.21 × 10^2^      CuL~2~

  Dendropanax morbifera active compound                                                                                             7.4       5.06 × 10^2^      CuL

  Desferrioxamine (Deferoxamine, Desferal, DFO)                                                                                     11.4      4.98 × 10^−2^     CuH~2~L^+^

  (S)-*N*-(3-(3-6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-\                                                                     6.3       1.47 × 10^4^      CuL
  methoxypyridin-2-amine                                                                                                                                        

  4, 5-*O*-Dicaffeoyl-1-*O*-(malic acid methyl ester)-quinic acid\                                                                  7.4       5.06 × 10^2^      CuL
  (R~1~, R~2~, R~3~, R~4~, or R~5~ = caffeoyl)                                                                                                                  

  Dihydromyricetin                                                                                                                  9.3       5.30              CuL~2~

  5-(3,4-Dihydroxybenzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione                                                                   7.4       5.06 × 10^2^      CuL

  7,8-Dihydroxycoumarin derivative DHC12                                                                                            7.4       5.06 × 10^2^      CuL

  3′,4′-Dihydroxyflavone                                                                                                            7.4       5.06 × 10^2^      CuL

  7,8-Dihydroxyflavone                                                                                                              7.4       5.06 × 10^2^      CuL

  5,7-Dihydroxy-4′-methoxyflavone                                                                                                   6.6       4.58 × 10^3^      CuL

  (*E*)-3, 4-Dihydroxystyryl aralkyl sulfones                                                                                       7.4       5.06 × 10^2^      CuL

  (*E*)-3, 4-Dihydroxystyryl aralkyl sulfoxides                                                                                     7.4       5.06 × 10^2^      CuL

  5,3′-Dihydroxy-3,7,4′-trimethoxyflavone                                                                                           6.6       4.58 × 10^3^      CuL

  2-\[\[(1,1-Dimethylethyl) oxidoimino\]-methyl\]-3,5,6-trimethylpyrazine                                                           9.6       2.98              CuL

  DKP                                                                                                                               8.1       8.43 × 10^1^      CuL

  [l]{.smallcaps}-DOPA (levodopa, CVT-301)                                                                                          15.2      7.95 × 10^−6^     CuH~−2~L^3−^

  DOPA-derived peptido-mimetics (deprotected)                                                                                       15.2      7.95 × 10^−6^     CuH~−2~L~2~

  DOPA-derived peptido-mimetics (protected)                                                                                         7.4       5.06 × 10^2^      CuL

  [l]{.smallcaps}-DOPA deuterated                                                                                                   15.2      7.95 × 10^−6^     CuH~−2~L^3−^

  Doxycycline                                                                                                                       8.9       1.28 × 10^1^      CuL

  Droxidopa                                                                                                                         15.2      7.95 × 10^−6^     CuH~−2~L^3−^

  Echinacoside                                                                                                                      7.4       5.06 × 10^2^      CuL

  Ellagic acid                                                                                                                      7.4       5.06 × 10^2^      CuL

  Entacapone (comtan, ASI-6)                                                                                                        10.1      8.00 × 10^−1^     CuL~2~^2−^

  Enzastaurin                                                                                                                       10.3      5.35 × 10^−1^     CuL~2~

  Epigallocatechin-3-gallate                                                                                                        6.1       1.33 × 10^5^      CuH~2~L~2~

  Etidronate (HEDPA)                                                                                                                9         1.11 × 10^1^      CuL^2−^

  Exifone                                                                                                                           6.3       1.51 × 10^4^      CuHL

  F13714,\                                                                                                                          9.7       1.86              CuL~2~
  F15599                                                                                                                                                        

  Farrerol                                                                                                                          11.1      8.29 × 10^−2^     CuL

  Fisetin (3,3′,4′,7-tetra-hydroxy-flavone)                                                                                         7.4       5.06 × 10^2^      CuL

  Fraxetin                                                                                                                          7.4       5.06 × 10^2^      CuL

  Galangin                                                                                                                          9.1       8.20              CuL

  Gallic acid derivatives                                                                                                           6.3       1.51 × 10^4^      CuHL^−^

  Gallocatechin                                                                                                                     9.3       5.30              CuL~2~

  Garcinol                                                                                                                          7.4       5.06 × 10^2^      CuL

  Genistein                                                                                                                         11.1      8.29 × 10^−2^     CuL

  Glutamine                                                                                                                         7.3       5.38 × 10^2^      CuL^+^

  Glutathione derivatives                                                                                                           6.2       7.23 × 10^4^      CuL^−^

  Glutathione-hydroxy-quinoline compound                                                                                            9.4       5.00              CuH~−1~L^+^

  Glutathione-[l]{.smallcaps}-DOPA compound                                                                                         13.5      3.98 × 10^−4^     CuH~−1~L

  Gly-N-C-DOPA                                                                                                                      15.2      7.95 × 10^−6^     CuH~−2~L^3−^

  GSK2795039                                                                                                                        12        1.02 × 10^−2^     CuL~2~

  Guanabenz                                                                                                                         10.3      5.35 × 10^−1^     CuL~2~

  Hesperidin                                                                                                                        11.1      8.29 × 10^−2^     CuL

  Hinokitiol                                                                                                                        7.3       6.69 × 10^2^      CuL^+^

  8-HQ-MC-5 (VK-28)                                                                                                                 14.2      5.91 × 10^−5^     CuL~2~

  4-Hydroxyisophthalic acid                                                                                                         6.3       2.06 × 10^4^      CuL

  1-Hydroxy-2-pyridinone derivatives                                                                                                8.4       4.26 × 10^1^      CuL~2~

  3-Hydroxy-4(1*H*)pyridinone (Deferiprone)                                                                                         10.2      6.60 × 10^−1^     CuL~2~

  3-Hydroxy-4(1*H*)pyridinone derivatives (R = H)                                                                                   10.2      6.60 × 10^−1^     CuL~2~

  8-Hydroxyquinoline                                                                                                                14.2      5.91 × 10^−5^     CuL~2~

  8-Hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone                                                                       14.2      5.91 × 10^−5^     CuL~2~

  Hydroxy-quinoline-propargyl hybrids (HLA20)                                                                                       14.2      5.91 × 10^−5^     CuL~2~

  Hydroxytyrosol butyrate                                                                                                           7.4       5.06 × 10^2^      CuL

  Hyperoside                                                                                                                        9.1       8.20              CuL

  IC87201                                                                                                                           6.1       1.90 × 10^7^      CuHL

  Icariin                                                                                                                           6.6       4.58 × 10^3^      CuL

  Icariside II                                                                                                                      6.6       4.58 × 10^3^      CuL

  l-(7-Imino-3-propyl-2,3-dihydrothiazolo\[4,5-*d*\]pyrimidin\                                                                      6.1       4.37 × 10^5^      CuL~2~
  -6(7*H*)-yl)urea                                                                                                                                              

  Imipramine                                                                                                                        6.3       1.47 × 10^4^      CuL^2+^

  Isobavachalcone                                                                                                                   6.2       8.13 × 10^4^      CuL^+^

  Isochlorogenic acid                                                                                                               8.3       5.04 × 10^1^      CuL^−^

  Isoquercetin (isoquercitrin)                                                                                                      9.1       8.20              CuL

  Kaempferol                                                                                                                        9.1       8.20              CuL

  KR33493                                                                                                                           7.3       5.93 × 10^2^      CuL

  Kukoamine                                                                                                                         7.4       5.06 × 10^2^      CuL

  Lestaurtinib                                                                                                                      10.3      5.35 × 10^−1^     CuL~2~

  Lipoic acid                                                                                                                       6.1       4.41 × 10^5^      CuL^+^

  Luteolin                                                                                                                          7.4       5.06 × 10^2^      CuL

  M10\                                                                                                                              14.2      5.91 × 10^−5^     CuL~2~
  M30 (VAR10303)\                                                                                                                                               
  M99                                                                                                                                                           

  Macranthoin G                                                                                                                     7.4       5.06 × 10^2^      CuL

  Magnesium lithospermate B                                                                                                         7.4       5.06 × 10^2^      CuL

  *α*-mangostin                                                                                                                     7.4       5.06 × 10^2^      CuL

  *γ*-Mangostin                                                                                                                     7.4       5.06 × 10^2^      CuL

  MAOI-1                                                                                                                            9.3       5.30              CuL~2~

  MAOI-2                                                                                                                            10.3      5.35 × 10^−1^     CuL~2~

  MAOI-4                                                                                                                            6.3       1.47 × 10^4^      CuL

  MAOI-8                                                                                                                            6.1       1.90 × 10^7^      CuHL

  Metformin (met)                                                                                                                   6.3       1.61 × 10^4^      CuL^+^

  Methoxy-6-acetyl-7-methylijuglone                                                                                                 14        1.05 × 10^−4^     CuL~2~

  *N*′-(4-methylbenzylidene)-5-phenylisoxazole-3-carbohydrazide                                                                     6.3       1.38 × 10^4^      CuL

  Minocycline                                                                                                                       11.6      2.83 × 10^−2^     CuL

  Mitomycin C                                                                                                                       7.1       9.14 × 10^2^      CuL

  Morin                                                                                                                             6.1       2.27 × 10^15^     CuH~3~L

  \[18F\]MPPF                                                                                                                       10.3      5.35 × 10^−1^     CuL~2~

  MSX-3                                                                                                                             6.1       2.01 × 10^6^      CuL

  Myricetin\                                                                                                                        9.1       8.20              CuL
  Myricitrin                                                                                                                                                    

  Naringin                                                                                                                          6.9       1.58 × 10^3^      CuHL

  Naringenin                                                                                                                        6.9       1.58 × 10^3^      CuHL

  Nicotinamide adenine dinucleotide phosphate (NADPH)                                                                               6.4       8.91 × 10^3^      CuL

  Nicotinamide mononucleotide                                                                                                       6.1       2.01 × 10^6^      CuL

  Nitecapone                                                                                                                        10.1      8.00 × 10^−1^     CuL~2~^2−^

  Nordihydroguaiaretic acid                                                                                                         7.4       5.06 × 10^2^      CuL

  Oleuropein                                                                                                                        7.4       5.06 × 10^2^      CuL

  Opicapone                                                                                                                         10.1      8.00 × 10^−1^     CuL~2~

  P7C3                                                                                                                              7.8       3.76 × 10^2^      Cu~2~H~−2~L~2~^+^

  PBT2                                                                                                                              12.4      4.04 × 10^−3^     CuL^+^

  PBT434                                                                                                                            11.2      7.21 × 10^−2^     CuL^+^

  Petunidin                                                                                                                         7.4       5.06 × 10^2^      CuL

  Phenothiazine 2Bc (n=0)                                                                                                           10.3      5.35 × 10^−1^     CuL~2~^2+^

  Phenothiazine 2Bc (n=1)                                                                                                           6.3       1.47 × 10^4^      CuL^2+^

  Phenylhydroxamates                                                                                                                7         1.46 × 10^3^      CuL

  Piceatannol                                                                                                                       7.4       5.06 × 10^2^      CuL

  Pinostrobin (5-hydroxy-7-methoxy-flavone)                                                                                         6.6       4.58 × 10^3^      CuL^+^

  Piperazine-8-OH-quinolone hybrid                                                                                                  14.2      5.91 × 10^−5^     CuL~2~

  Preladenant                                                                                                                       10.3      5.35 × 10^−1^     CuL~2~

  Promethazine                                                                                                                      8.2       7.99 × 10^1^      CuL^2+^

  Protocatechuic acid                                                                                                               8.1       8.13 × 10^1^      CuL^−^

  Protosappanin A                                                                                                                   7.4       5.06 × 10^2^      CuL

  Punicalangin                                                                                                                      8.2       6.89 × 10^1^      CuL

  Pyrazolobenzothiazine-based carbothioamides                                                                                       6.1       4.66 × 10^5^      CuL

  Pyrimidinone 8                                                                                                                    10.3      5.35 × 10^−1^     CuL~2~

  Q1\                                                                                                                               14.2      5.91 × 10^−5^     CuL~2~
  Q4                                                                                                                                                            

  Quercetin                                                                                                                         9.1       8.20              CuL^3−^

  Quinoline derivatives SUMOylation activators                                                                                      7.2       7.26 × 10^2^      CuL^2+^

  Radotinib                                                                                                                         10.6      2.35 × 10^−1^     CuL~2~

  Riboflavin                                                                                                                        6.1       1.65 × 10^5^      CuHL^3+^

  Rifampicin (ASI-3)                                                                                                                6.5       6.97 × 10^3^      CuL

  Rimonabant                                                                                                                        8.1       8.43 × 10^1^      CuL

  Rosmarinic acid                                                                                                                   7.4       5.06 × 10^2^      CuL

  Rotigotine                                                                                                                        6.1       1.45 × 10^8^      CuL~2~

  Rutin                                                                                                                             9.1       8.20              CuL

  Salicylate, sodium salt                                                                                                           6.3       2.06 × 10^4^      CuL

  Salvianolic acid B                                                                                                                7.4       5.06 × 10^2^      CuL

  SCH58261\                                                                                                                         9.1       7.58              CuL~2~
  SCH412348                                                                                                                                                     

  ST1535\                                                                                                                           9.1       7.58              CuL~2~
  ST4206                                                                                                                                                        

  Staurosporine                                                                                                                     10.3      5.35 × 10^−1^     CuL~2~

  Stemazole                                                                                                                         6.1       4.66 × 10^5^      CuL

  Sulfuretin                                                                                                                        7.4       5.06 × 10^2^      CuL

  Tannic acid                                                                                                                       6.1       1.84 × 10^5^      CuL

  Tanshinol                                                                                                                         7.4       5.06 × 10^2^      CuL

  Taurine                                                                                                                           6.1       1.23 × 10^7^      CuL^+^

  Taxifolin                                                                                                                         10.4      4.55 × 10^−1^     CuL^2−^

  Tectorigenin                                                                                                                      11.1      8.29 × 10^−2^     CuL

  Tetracycline                                                                                                                      6.4       1.08 × 10^4^      CuL

  Tolcapone (ASI-7)                                                                                                                 10.1      8.00 × 10^−1^     CuL~2~

  Transilitin                                                                                                                       7.4       5.06 × 10^2^      CuL

  o-Trensox                                                                                                                         22.9      1.51 × 10^−13^    CuL^4−^

  2′, 3′, 4′-Trihydroxyflavone                                                                                                      9.3       5.30              CuL~2~^2−^

  2,3,3-Trisphosphonate                                                                                                             14        9.98 × 10^−5^     CuL~2~

  V81444                                                                                                                            9.7       1.86              CuL~2~

  VAS3947\                                                                                                                          6.1       4.37 × 10^5^      CuL~2~
  VAS2870                                                                                                                                                       

  Verbascoside                                                                                                                      7.3       6.02 × 10^2^      CuH~−1~L

  WIN 55, 212-2                                                                                                                     10.3      5.35 × 10^−1^     CuL~2~^2+^

  WR-1065                                                                                                                           6.6       3.67 × 10^3^      CuL^2+^

  Zonisamide                                                                                                                        7.4       4.62 × 10^2^      CuL
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

biomolecules-09-00269-t004_Table 4

###### 

pCu(I) and *K*~d~ values, and the most abundant Cu(I) complex, obtained at physiologically relevant conditions: pH = 7.4, *c*~Cu~ = 10^−6^ mol/L, and *c*~L~ = 10^−5^ mol/L. See caption of [Table 3](#biomolecules-09-00269-t003){ref-type="table"} for other notes.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound Name(s)                                                                                                                  pCu(I)   *K*~d~ (nmol/L)   Most Abundant Complex
  --------------------------------------------------------------------------------------------------------------------------------- -------- ----------------- -----------------------
  7DH\                                                                                                                              6.3      8.38 × 10^3^      CuL~2~
  7MH                                                                                                                                                          

  8A\                                                                                                                               6.3      8.38 × 10^3^      CuL~2~
  8B\                                                                                                                                                          
  8C                                                                                                                                                           

  8E\                                                                                                                               6.2      1.87 × 10^4^      CuL
  8F                                                                                                                                                           

  ACPT-I                                                                                                                            6        2.54 × 10^8^      CuL~2~

  ADX88178                                                                                                                          7.7      1.77 × 10^2^      CuL

  Alvespimycin                                                                                                                      6        7.98 × 10^7^      CuL~2~^+^

  3-(7-Amino-5-(cyclohexylamino)-\[1,2,4\]triazolo\[1,5-*a*\]\                                                                      6        7.98 × 10^7^      CuL~2~
  \[1,3,5\]triazin-2-yl)-2-cyanoacrylamide                                                                                                                     

  Aminothiazoles derivatives as SUMOylation activators                                                                              6        2.66 × 10^6^      CuL~2~

  AMN082                                                                                                                            6        7.98 × 10^7^      CuL~2~

  Antagonist of the A(2A) adenosine receptor (derivative 49)                                                                        6        3.06 × 10^7^      CuL~2~

  8-Benzyl-tetrahydropyrazino\[2,1-*f*\]purinedione (derivative 57)                                                                 7.6      2.17 × 10^2^      CuL

  (−)-*N*6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-*N*6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]thiazole-2,6-diamine derivatives   6        7.98 × 10^7^      CuL~2~^+^

  2,2′-bipyridyl                                                                                                                    6.2      1.87 × 10^4^      CuL^+^

  Carbazole-derived compounds                                                                                                       6        7.98 × 10^7^      CuL~2~^+^

  Ceftriaxone                                                                                                                       6        2.54 × 10^8^      CuL~2~

  Clioquinol                                                                                                                        7.2      5.79 × 10^2^      CuL~2~^−^

  "Compound 1"                                                                                                                      6        7.98 × 10^7^      CuL~2~^+^

  "Compound 8"                                                                                                                      7.6      2.17 × 10^2^      CuL

  "Compound 21", derivative of 3-methyl-1-(2,4,6-trihydroxy\                                                                        6        2.54 × 10^8^      CuL~2~^−^
  phenyl) butan-1-one                                                                                                                                          

  "Compound (−)-21a", derivative of *N*-6-(2-(4-(1*H*-indol-5-yl)\                                                                  6        7.98 × 10^7^      CuL~2~^+^
  piperazin-1-yl)ethyl)-*N*-6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]thiazole-2,6-diamine                                                                        

  Creatine                                                                                                                          6        2.54 × 10^8^      CuL~2~^−^

  D512                                                                                                                              6        7.98 × 10^7^      CuL~2~^+^

  D607(bipyridyl-D2R/D3R agonist hybrid)                                                                                            6.2      1.87 × 10^4^      CuL

  DA-2 (8D)                                                                                                                         6.3      8.38 × 10^3^      CuL~2~

  DA-3                                                                                                                              6        7.98 × 10^7^      CuL~2~

  DA-4                                                                                                                              6        7.98 × 10^7^      CuL~2~

  Dabigatran etexilate                                                                                                              6        7.98 × 10^7^      CuL~2~

  Dabrafenib                                                                                                                        7.7      1.77 × 10^2^      CuL

  2-\[\[(1,1-Dimethylethyl) oxidoimino\]-methyl\]-3,5,6-trimethylpyrazine                                                           6.9      1.07 × 10^3^      CuH~2~L~2~

  DKP                                                                                                                               7.4      3.64 × 10^2^      CuL

  Doxycycline                                                                                                                       9.2      1.26 × 10^1^      Cu~2~L

  Enzastaurin                                                                                                                       6        7.98 × 10^7^      CuL~2~

  F13714\                                                                                                                           6        7.83 × 10^5^      Cu~2~L
  F15599                                                                                                                                                       

  Glutathione-hydroxy-quinoline compound                                                                                            6.3      8.38 × 10^3^      CuL~2~^−^

  Glutathione derivatives                                                                                                           15.2     6.21 × 10^−6^     CuHL^−^

  Guanabenz                                                                                                                         6        7.98 × 10^7^      CuL~2~

  8-HQ-MC-5 (VK-28)                                                                                                                 6.3      8.38 × 10^3^      CuL~2~

  8-hydroxyquinoline                                                                                                                6.3      8.38 × 10^3^      CuL~2~^−^

  8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone                                                                       6.3      8.38 × 10^3^      CuL~2~

  Hydroxy-quinoline-propargyl hybrids (HLA20)                                                                                       6.3      8.38 × 10^3^      CuL~2~

  l-(7-Imino-3-propyl-2,3-dihydrothiazolo \[4,5-*d*\]\                                                                              7.6      2.17 × 10^2^      CuL
  pyrimidin-6(7*H*)-yl)urea                                                                                                                                    

  KR33493                                                                                                                           6        2.54 × 10^8^      CuL~2~

  Lestaurtinib                                                                                                                      6        7.98 × 10^7^      CuL~2~

  M10\                                                                                                                              6.3      8.38 × 10^3^      CuL~2~
  M30 (VAR10303)\                                                                                                                                              
  M99                                                                                                                                                          

  MAOI-2                                                                                                                            6        7.98 × 10^7^      CuL~2~

  \[18F\]MPPF                                                                                                                       6        7.98 × 10^7^      CuL~2~

  PBF-509                                                                                                                           6        7.98 × 10^7^      CuL~2~

  PBT2                                                                                                                              6.3      8.38 × 10^3^      CuL~2~

  Phenothiazine 2Bc (n=0)                                                                                                           6        7.98 × 10^7^      CuL~2~^+^

  Piperazine-8-OH-quinolone hybrid                                                                                                  6.3      8.38 × 10^3^      CuL~2~

  Preladenant                                                                                                                       6        7.98 × 10^7^      CuL~2~

  Promethazine                                                                                                                      6        7.98 × 10^7^      CuL~2~^+^

  Pyrimidinone 8                                                                                                                    6        7.98 × 10^7^      CuL~2~

  Q1\                                                                                                                               6.3      8.38 × 10^3^      CuL~2~
  Q4                                                                                                                                                           

  Radotinib                                                                                                                         6.2      1.87 × 10^4^      CuL

  Rifampicin (ASI-3)                                                                                                                9.2      1.26 × 10^1^      Cu~2~L

  Rimonabant                                                                                                                        7.4      3.64 × 10^2^      CuL

  Rotigotine                                                                                                                        7.7      1.77 × 10^2^      CuL

  SCH58261\                                                                                                                         6        7.98 × 10^7^      CuL~2~
  SCH412348                                                                                                                                                    

  ST1535 ST4206                                                                                                                     6        7.98 × 10^7^      CuL~2~

  Staurosporine                                                                                                                     6        7.98 × 10^7^      CuL~2~

  V81444                                                                                                                            6        2.66 × 10^6^      CuL~2~

  VAS3947\                                                                                                                          7.6      2.17 × 10^2^      CuL
  VAS2870                                                                                                                                                      

  WIN 55, 212-2                                                                                                                     6        7.98 × 10^7^      CuL~2~^+^

  WR-1065                                                                                                                           7.6      2.17 × 10^2^      CuL
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

biomolecules-09-00269-t005_Table 5

###### 

pFe(III) and *K*~d~ values, and the most abundant Fe(III) complex, obtained at physiologically relevant conditions: pH = 7.4, *c*~Fe~ = 10^--6^ mol/L, and *c*~L~ = 10^--5^ mol/L. See caption of [Table 3](#biomolecules-09-00269-t003){ref-type="table"} for other notes.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound Name(s)                                                                                                          pFe(III)   *K*~d~ (nmol/L)   Most Abundant Complex
  ------------------------------------------------------------------------------------------------------------------------- ---------- ----------------- -----------------------
  7DH\                                                                                                                      20.6       2.15 × 10^−1^     FeL~3~
  7MH                                                                                                                                                    

  8A\                                                                                                                       20.6       2.15 × 10^−1^     FeL~3~
  8B\                                                                                                                                                    
  8C                                                                                                                                                     

  8E\                                                                                                                       21.5       3.01 × 10^−2^     FeH~--2~L~2~
  8F                                                                                                                                                     

  *N*-Acetyl cysteine                                                                                                       16.1       4.59 × 10^9^      FeL~2~^−^

  ACPT-I                                                                                                                    16.1       9.59 × 10^7^      FeL~2~

  Ambroxol                                                                                                                  16.3       1.70 × 10^4^      FeL^2+^

  Apigenin                                                                                                                  16.1       7.55 × 10^8^      FeL^2+^

  Apomorphine                                                                                                               16.3       1.35 × 10^4^      FeL~2~

  [l]{.smallcaps}-Arginine                                                                                                  16.1       1.18 × 10^12^     FeL^3+^

  Aromadendrin                                                                                                              16.1       7.55 × 10^8^      FeL

  Ascorbic acid                                                                                                             16.1       4.99 × 10^17^     FeL~2~^+^

  ASI-1                                                                                                                     16.8       2.28 × 10^3^      FeL

  ASI-5                                                                                                                     18         1.06 × 10^2^      FeL

  Astilbin                                                                                                                  16.3       1.35 × 10^4^      FeL~2~

  Baicalein                                                                                                                 16.1       7.55 × 10^8^      FeL^2+^

  4*H*-1-benzopyran-4-one                                                                                                   18.1       8.14 × 10^1^      FeL~2~

  2,2′-bipyridyl                                                                                                            21.5       3.01 × 10^−2^     FeH~−2~L~2~^+^

  4-((5-bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic acid (LX007, ZL006)                                         16.1       4.46 × 10^7^      FeL~2~

  C-3 (α carboxyfullerene)                                                                                                  16.1       2.54 × 10^10^     FeL~2~

  Caffeic acid amide analogues                                                                                              16.3       1.35 × 10^4^      FeL~2~

  Carbidopa                                                                                                                 16.2       2.96 × 10^4^      FeL

  Carnosic acid                                                                                                             16.3       1.35 × 10^4^      FeL~2~

  Catechin                                                                                                                  16.1       4.49 × 10^17^     FeHL

  Ceftriaxone                                                                                                               16.1       9.59 × 10^7^      FeL~2~

  Celastrol                                                                                                                 19.2       6.33              FeL~2~

  Chebulagic acid                                                                                                           16.1       7.45 × 10^5^      FeHL

  Chlorogenic acid                                                                                                          16.1       1.07 × 10^7^      FeL

  3′-*O*-(3-Chloropivaloyl) quercetin                                                                                       16.1       7.55 × 10^8^      FeL

  Chrysin                                                                                                                   16.1       7.55 × 10^8^      FeL^+^

  Clioquinol                                                                                                                20.6       2.15 × 10^−1^     FeL~3~

  Clioquinol-selegiline hybrid                                                                                              22.9       1.07 × 10^−3^     FeL~2~

  Clovamide analogues (R~1~ and R~2~ = OH, and/or R~3~ and R~4~ = OH)                                                       16.3       1.35 × 10^4^      FeL~2~

  "Compound (−)-8a"                                                                                                         16.3       1.35 × 10^4^      FeL~2~

  "Compound 21", derivative of 3-methyl-1-(2,4,6-trihydroxyphenyl) butan-1-one                                              16.1       9.59 × 10^7^      FeL~2~^+^

  Creatine                                                                                                                  16.1       9.59 × 10^7^      FeL~2~^+^

  Cudraflavone B                                                                                                            16.1       7.55 × 10^8^      FeL

  Curcumin                                                                                                                  16.6       4.09 × 10^3^      FeL

  Cyanidin                                                                                                                  16.3       1.35 × 10^4^      FeL~2~

  D607 (bipyridyl-D2R/D3R agonist hybrid)                                                                                   21.5       3.01 × 10^−2^     FeH~−2~L~2~

  DA-2 (8D)                                                                                                                 20.6       2.15 × 10^−1^     FeL~3~

  DA-3                                                                                                                      17.2       5.61 × 10^2^      FeL~2~

  DA-4                                                                                                                      17.2       5.61 × 10^2^      FeL~2~

  Deferasirox                                                                                                               23.5       3.22 × 10^−4^     FeL~2~^3−^

  Delphinidin                                                                                                               16.3       1.35 × 10^4^      FeL~2~

  Demethoxycurcumin                                                                                                         16.8       2.28 × 10^3^      FeL

  Dendropanax morbifera active compound                                                                                     16.3       1.35 × 10^4^      FeL~2~

  Desferrioxamine (Deferoxamine, Desferal, DFO)                                                                             26.8       1.81 × 10^−7^     FeHL^+^

  4,5-*O*-Dicaffeoyl-1-*O*-(malic acid methyl ester)-quinic acid derivatives (R~1~, R~2~, R~3~, R~4~, or R~5~ = caffeoyl)   16.3       1.35 × 10^4^      FeL~2~

  Dihydromyricetin                                                                                                          16.3       1.35 × 10^4^      FeL~2~

  5-(3,4-dihydroxybenzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione                                                           16.3       1.35 × 10^4^      FeL~2~^−^

  7,8-dihydroxycoumarin derivative DHC12                                                                                    16.3       1.35 × 10^4^      FeL~2~

  3′,4′-dihydroxyflavone                                                                                                    16.3       1.35 × 10^4^      FeL~2~^−^

  7,8-dihydroxyflavone                                                                                                      16.3       1.35 × 10^4^      FeL~2~^−^

  5,7-dihydroxy-4′-methoxyflavone                                                                                           18.1       8.14 × 10^1^      FeL~2~

  (*E*)-3,4-dihydroxystyryl aralkyl sulfones                                                                                16.3       1.35 × 10^4^      FeL~2~^−^

  (*E*)-3,4-dihydroxystyryl aralkyl sulfoxides                                                                              16.3       1.35 × 10^4^      FeL~2~^−^

  5,3′-dihydroxy-3,7,4′-trimethoxyflavone                                                                                   18.1       8.14 × 10^1^      FeL~2~

  2-\[\[(1,1-Dimethylethyl) oxidoimino\]-methyl\]-3,5,6-trimethylpyrazine                                                   16.1       1.86 × 10^10^     FeL

  DKP                                                                                                                       16.1       7.43 × 10^21^     FeL~2~

  [l]{.smallcaps}-DOPA (levodopa, CVT-301)                                                                                  16.2       2.96 × 10^4^      FeL

  DOPA-derived peptido-mimetics (deprotected)                                                                               16.2       2.96 × 10^4^      FeL

  DOPA-derived peptido-mimetics (protected)                                                                                 16.3       1.35 × 10^4^      FeL~2~

  [l]{.smallcaps}-dopa deuterated                                                                                           16.2       2.96 × 10^4^      FeL

  Doxycycline                                                                                                               18.1       7.22 × 10^1^      FeL~2~

  Droxidopa                                                                                                                 16.2       2.96 × 10^4^      FeL

  Echinacoside                                                                                                              16.3       1.35 × 10^4^      FeL~2~

  Ellagic acid                                                                                                              16.3       1.35 × 10^4^      FeL~2~

  Entacapone (comtan, ASI-6)                                                                                                19.3       3.99              FeL~3~^3−^

  Epicatechin                                                                                                               16.3       1.35 × 10^4^      FeL~2~

  Epigallocatechin-3-gallate                                                                                                16.1       7.45 × 10^5^      FeHL

  Etidronate (HEDPA)                                                                                                        23.5       3.22 × 10^−4^     FeH~−1~L

  Exifone                                                                                                                   16.1       7.45 × 10^5^      FeHL

  Farrerol                                                                                                                  16.1       7.55 × 10^8^      FeL

  Fiset (3,3′,4′,7-tetra-hydroxy-flavone)                                                                                   16.3       1.35 × 10^4^      FeL~2~

  Fraxetin                                                                                                                  16.3       1.35 × 10^4^      FeL~2~^−^

  Galangin                                                                                                                  27.0       9.36 × 10^−8^     FeH~−1~L

  Gallic acid derivatives                                                                                                   16.1       7.45 × 10^5^      FeHL

  Garcinol                                                                                                                  16.3       1.35 × 10^4^      FeL~2~

  Genistein                                                                                                                 16.1       7.55 × 10^8^      FeL

  Glutathione-hydroxy-quinoline compound                                                                                    18         1.04 × 10^2^      FeH~−2~L^+^

  Glutathione-[l]{.smallcaps}-DOPA compound                                                                                 16.3       1.35 × 10^4^      FeL~2~

  Gly-N-C-DOPA                                                                                                              16.2       2.96 × 10^4^      FeL

  Hesperidin                                                                                                                16.1       7.55 × 10^8^      FeL

  Hinokitiol                                                                                                                16.1       4.30 × 10^8^      FeL^2+^

  8-HQ-MC-5 (VK-28)                                                                                                         20.6       2.15 × 10^−1^     FeL~3~

  4-Hydroxyisophthalic acid                                                                                                 16.1       1.64 × 10^6^      FeL~3~

  1-Hydroxy-2-pyridinone derivatives                                                                                        17.7       1.50 × 10^2^      FeL~3~

  3-Hydroxy-4(1*H*)pyridinone (Deferiprone)                                                                                 19.3       3.92              FeL~3~

  3-Hydroxy-4(1*H*)pyridinone derivatives (R = H)                                                                           19.3       3.92              FeL~3~

  8-Hydroxyquinoline                                                                                                        20.6       2.15 × 10^−1^     FeL~3~

  8-Hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone                                                               20.6       2.15 × 10^−1^     FeL~3~

  Hydroxy-quinoline-propargyl hybrids (HLA20)                                                                               20.6       2.15 × 10^−1^     FeL~3~

  Hydroxytyrosol butyrate                                                                                                   16.3       1.35 × 10^4^      FeL~2~^−^

  Hyperoside                                                                                                                27.0       9.36 × 10^−8^     FeH~−1~L

  Icariin                                                                                                                   18.1       8.14 × 10^1^      FeL~2~

  Icariside II                                                                                                              18.1       8.14 × 10^1^      FeL~2~

  Isobavachalcone                                                                                                           16.1       3.23 × 10^8^      FeL~2~^+^

  Isochlorogenic acid                                                                                                       16.1       1.07 × 10^7^      FeL

  Isoquercetin (isoquercitrin)                                                                                              27.0       9.36 × 10^−8^     FeH~−1~L

  Kaempferol                                                                                                                27.0       9.36 × 10^−8^     FeH~−1~L

  Kaempferol, 3-*O*-a-L arabino-furanoside-7-*O*-a-L-\                                                                      18.1       8.14 × 10^1^      FeL~2~
  rhamno-pyranoside                                                                                                                                      

  KR33493                                                                                                                   16.3       1.06 × 10^4^      FeL~2~

  Kukoamine                                                                                                                 16.3       1.35 × 10^4^      FeL~2~

  Luteolin                                                                                                                  16.3       1.35 × 10^4^      FeL~2~

  M10\                                                                                                                      20.6       2.15 × 10^−1^     FeL~3~
  M30 (VAR10303)\                                                                                                                                        
  M99                                                                                                                                                    

  Macranthoin G                                                                                                             16.3       1.35 × 10^4^      FeL~2~

  Magnesium lithospermate B                                                                                                 16.3       1.35 × 10^4^      FeL~2~

  α-mangostin                                                                                                               16.3       1.35 × 10^4^      FeL~2~

  γ-mangostin                                                                                                               16.3       1.35 × 10^4^      FeL~2~

  Metformin (Met)                                                                                                           16.1       1.36 × 10^9^      FeL~2~^+^

  MitoQ                                                                                                                     16.1       5.72 × 10^10^     FeL~2~

  Morin                                                                                                                     18.1       8.14 × 10^1^      FeL~2~

  Myricetin\                                                                                                                27.0       9.36 × 10^−8^     FeH~−1~L
  Myricitrin                                                                                                                                             

  Naringenin                                                                                                                16.1       7.55 × 10^8^      FeL

  Naringin                                                                                                                  16.1       7.55 × 10^8^      FeL

  Nicotinamide adenine dinucleotide phosphate (NADPH)                                                                       16.1       6.01 × 10^10^     FeL~2~

  Nitecapone                                                                                                                16.8       2.04 × 10^3^      FeL~2~^−^

  Nordihydroguaiaretic acid                                                                                                 16.3       1.35 × 10^4^      FeL~2~

  Oleuropein                                                                                                                16.3       1.35 × 10^4^      FeL~2~^−^

  Opicapone                                                                                                                 16.8       2.04 × 10^3^      FeL~2~

  PBT2                                                                                                                      20.6       2.15 × 10^−1^     FeL~3~

  PBT434                                                                                                                    16.1       3.22 × 10^9^      FeL^2+^

  Petunidin                                                                                                                 16.3       1.35 × 10^4^      FeL~2~

  Phenylhydroxamates                                                                                                        16.1       9.46 × 10^4^      FeL~2~

  Piceatannol                                                                                                               16.3       1.35 × 10^4^      FeL~2~

  Pinostrobin (5-hydroxy-7-methoxy-flavone)                                                                                 18.1       8.14 × 10^1^      FeL~2~

  Piperazine-8-OH-quinolone hybrid                                                                                          20.6       2.15 × 10^−1^     FeL~3~

  Protocatechuic acid                                                                                                       22.2       6.16 × 10^−3^     FeL~2~^3−^

  Protosappanin A                                                                                                           16.3       1.35 × 10^4^      FeL~2~

  Punicalangin                                                                                                              16.1       1.14 × 10^12^     FeL

  Pyridoxal isonicotinoyl hydrazone (PIH)                                                                                   22.9       1.07 × 10^−3^     FeL~2~

  Pyridoxal isonicotinoyl hydrazone derivatives:\                                                                           22.9       1.07 × 10^−3^     FeL~2~
  PCIH\                                                                                                                                                  
  PCTH\                                                                                                                                                  
  H2NPH\                                                                                                                                                 
  H2PPH                                                                                                                                                  

  Q1\                                                                                                                       20.6       2.15 × 10^−1^     FeL~3~
  Q4                                                                                                                                                     

  Quercetin                                                                                                                 27.0       9.36 × 10^−8^     FeH~--1~L^3−^

  Quinoline derivatives as SUMOylation activators                                                                           16.1       1.14 × 10^16^     FeL^2+^

  Radotinib                                                                                                                 21.5       3.01 × 10^−2^     FeH~−2~L~2~

  Rimonabant                                                                                                                16.1       7.43 × 10^21^     FeL~2~

  Rosmarinic acid                                                                                                           16.3       1.35 × 10^4^      FeL~2~

  Rutin                                                                                                                     27.0       9.36 × 10^−8^     FeH~−1~L

  Salicylate, sodium salt                                                                                                   16.1       1.64 × 10^6^      FeL~3~^3−^

  Salvianolic acid B                                                                                                        16.3       1.35 × 10^4^      FeL~2~

  Silibinin (silybin) A, B                                                                                                  16.1       1.99 × 10^19^     FeH~3~L^3+^

  Silydianin                                                                                                                16.1       1.99 × 10^19^     FeH~3~L^3+^

  Sulfuretin                                                                                                                16.3       1.35 × 10^4^      FeL~2~

  Tanshinol                                                                                                                 16.3       1.35 × 10^4^      FeL~2~

  Tannic acid                                                                                                               16.1       6.05 × 10^49^     Fe~4~L

  Taxifolin                                                                                                                 16.1       7.55 × 10^8^      FeL

  Tectorigenin                                                                                                              16.1       7.55 × 10^8^      FeL

  Tetracycline                                                                                                              16.1       8.35 × 10^10^     FeL~2~^2−^

  Tolcapone (ASI-7)                                                                                                         16.8       2.04 × 10^3^      FeL~2~^−^

  Transilitin                                                                                                               16.3       1.35 × 10^4^      FeL~2~

  *o*-Trensox                                                                                                               29.5       3.36 × 10^−10^    FeL^3−^

  2,3,3-Trisphosphonate                                                                                                     18         1.06 × 10^2^      FeL

  Verbascoside                                                                                                              16.3       1.35 × 10^4^      FeL~2~

  Zonisamide                                                                                                                16.1       1.86 × 10^11^     FeL~2~
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

pFe(II) and *K*~d~ values, and the most abundant Fe(II) complex, obtained at physiologically relevant conditions: pH = 7.4, *c*~Fe~ = 10^−6^ mol/L, and *c*~L~ = 10^−5^ mol/L. See caption of [Table 3](#biomolecules-09-00269-t003){ref-type="table"} for other notes.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound Name(s)                                                                                                                  pFe(II)   *K*~d~ (nmol/L)   Most Abundant Complex
  --------------------------------------------------------------------------------------------------------------------------------- --------- ----------------- -----------------------
  7DH\                                                                                                                              6.9       1.35 × 10^3^      FeL
  7MH                                                                                                                                                           

  8A\                                                                                                                               6.9       1.35 × 10^3^      FeL
  8B\                                                                                                                                                           
  8C                                                                                                                                                            

  8E\                                                                                                                               6.1       4.62 × 10^4^      FeL~2~
  8F                                                                                                                                                            

  ACPT-I                                                                                                                            6         1.20 × 10^7^      FeL

  Alvespimycin                                                                                                                      6         2.07 × 10^7^      FeL^2+^

  Aminothiazoles derivatives as SUMOylation activators                                                                              6         2.77 × 10^6^      FeL

  AMN082                                                                                                                            6         2.07 × 10^7^      FeL^2+^

  Apomorphine                                                                                                                       6         1.53 × 10^7^      FeHL

  [l]{.smallcaps}-Arginine                                                                                                          6         3.30 × 10^7^      FeL^2+^

  Ascorbic acid                                                                                                                     6         1.89 × 10^9^      FeL^+^

  ASI-1                                                                                                                             6         1.78 × 10^5^      FeL^+^

  ASI-5                                                                                                                             10.7      1.95 × 10^−1^     FeL

  Astilbin                                                                                                                          6         1.53 × 10^7^      FeHL

  Azilsartan                                                                                                                        6         2.53 × 10^15^     FeL~2~

  Baicalein                                                                                                                         9.9       1.09              FeL~2~^2−^

  Benserazide                                                                                                                       9.9       1.09              FeL~2~

  (−)-*N*6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-*N*6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]thiazole-2,6-diamine derivatives   6         2.07 × 10^7^      FeL^2+^

  2,2′-Bipyridyl                                                                                                                    6.1       4.62 × 10^4^      FeL~2~^2+^

  4-((5-bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic acid (LX007, ZL006)                                                 6         3.13 × 10^8^      FeL

  C-3 (α carboxyfullerene)                                                                                                          6         6.90 × 10^6^      FeL

  Caffeic acid amide analogues                                                                                                      6.7       2.02 × 10^3^      FeH~−1~L

  Carbazole-derived compounds                                                                                                       6         2.07 × 10^7^      FeL^2+^

  Carbidopa                                                                                                                         6.3       1.07 × 10^4^      FeL

  Carnosic acid                                                                                                                     6         1.53 × 10^7^      FeHL

  Catechin                                                                                                                          6         1.53 × 10^7^      FeHL

  Ceftriaxone                                                                                                                       6         1.20 × 10^7^      FeL

  Celastrol                                                                                                                         6         1.53 × 10^7^      FeHL

  CEP-1347                                                                                                                          6         1.53 × 10^7^      FeHL

  Chebulagic acid                                                                                                                   6         5.66 × 10^5^      FeL

  Chlorogenic acid                                                                                                                  6         2.93 × 10^6^      FeHL

  Clioquinol                                                                                                                        7.9       1.01 × 10^2^      FeL~2~

  Clioquinol-selegiline hybrid                                                                                                      7.1       6.37 × 10^2^      FeH~2~L~2~

  Clovamide analogues (R~1~ and R~2~ = OH, and/or R~3~ and R~4~ = OH)                                                               6         1.53 × 10^7^      FeHL

  "Compound 1"                                                                                                                      6         2.07 × 10^7^      FeL^2+^

  "Compound (−)-8a"                                                                                                                 6         1.53 × 10^7^      FeHL

  "Compound 21", derivative of 3-methyl-1-(2,4,6-trihydroxyphenyl) butan-1-one                                                      6         1.20 × 10^7^      FeL^+^

  "Compound (−)-21a", derivative of *N*-6-(2-(4-(1*H*-indol-5-yl)\                                                                  6         2.07 × 10^7^      FeL^2+^
  piperazin-1-yl)ethyl)-*N*-6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]thiazole-2,6-diamine                                                                         

  Creatine                                                                                                                          6         1.20 × 10^7^      FeL^+^

  Curcumin                                                                                                                          6         4.16 × 10^9^      FeH~2~L^+^

  Cyanidin                                                                                                                          6         1.53 × 10^7^      FeHL

  D512                                                                                                                              6         2.07 × 10^7^      FeL^2+^

  D607 (bipyridyl-D2R/D3R agonist hybrid)                                                                                           6.1       4.63 × 10^4^      FeL~2~

  DA-2 (8D)                                                                                                                         6.9       1.35 × 10^3^      FeL

  DA-3                                                                                                                              6         2.07 × 10^7^      FeL

  DA-4                                                                                                                              6         2.07 × 10^7^      FeL

  Dabigatran etexilate                                                                                                              6         2.07 × 10^7^      FeL

  Delphinidin                                                                                                                       9.9       1.09              FeL~2~

  Demethoxycurcumin                                                                                                                 6         1.78 × 10^5^      FeL

  Dendropanax morbifera                                                                                                             6         1.53 × 10^7^      FeHL

  Desferrioxamine (Deferoxamine, Desferal, DFO)                                                                                     6.2       2.24 × 10^4^      FeH~2~L^+^

  4,5-*O*-Dicaffeoyl-1-*O*-(malic acid methyl ester)-quinic acid derivatives (R~1~, R~2~, R~3~, R~4~, or R~5~ = caffeoyl)           6         1.53 × 10^7^      FeHL

  Dihydromyricetin                                                                                                                  9.9       1.09              FeL~2~

  5-(3,4-Dihydroxybenzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione                                                                   6         1.53 × 10^7^      FeHL^+^

  7, 8-Dihydroxycoumarin derivative DHC12                                                                                           6         1.53 × 10^7^      FeHL

  3′,4′-Dihydroxyflavone                                                                                                            14.8      1.58 × 10^−5^     FeL^+^

  7,8-Dihydroxyflavone                                                                                                              6         1.53 × 10^7^      FeHL^+^

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfones                                                                                        6         1.53 × 10^7^      FeHL^+^

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfoxides                                                                                      6         1.53 × 10^7^      FeHL^+^

  2-\[\[(1,1-Dimethylethyl) oxidoimino\]-methyl\]-3,5,6-trimethylpyrazine                                                           8.2       5.40 × 10^1^      FeL~2~

  DKP                                                                                                                               6         4.33 × 10^5^      FeL

  [l]{.smallcaps}-DOPA (levodopa, CVT-301)                                                                                          6.3       1.07 × 10^4^      FeL^−^

  DOPA-derived peptido-mimetics (deprotected)                                                                                       10.5      2.82 × 10^−1^     FeHL

  DOPA-derived peptido-mimetics (protected)                                                                                         6         1.53 × 10^7^      FeHL

  [l]{.smallcaps}-DOPA deuterated                                                                                                   6.3       1.07 × 10^4^      FeL^−^

  Doxycycline                                                                                                                       6         4.07 × 10^8^      FeL

  Droxidopa                                                                                                                         6.3       1.07 × 10^4^      FeL^−^

  Echinacoside                                                                                                                      6         1.53 × 10^7^      FeHL

  Ellagic acid                                                                                                                      6         1.53 × 10^7^      FeHL

  Entacapone (comtan, ASI-6)                                                                                                        12.7      1.65 × 10^−3^     FeL~2~^2−^

  Enzastaurin                                                                                                                       6         2.07 × 10^7^      FeL

  Epicatechin                                                                                                                       6         1.53 × 10^7^      FeHL

  Etidronate (HEDPA)                                                                                                                9.9       1.14              FeL^2−^

  F13714\                                                                                                                           6         2.77 × 10^6^      FeL
  F15599                                                                                                                                                        

  FIsetin (3,3′,4′,7-tetra-hydroxy-flavone)                                                                                         6         1.53 × 10^7^      FeHL

  Fraxetin                                                                                                                          6         1.53 × 10^7^      FeHL^+^

  Gallocatechin                                                                                                                     9.9       1.09              FeL~2~

  Garcinol                                                                                                                          6         1.53 × 10^7^      FeHL

  Glutamine                                                                                                                         6         7.54 × 10^5^      FeL^+^

  Glutathione-hydroxy-quinoline compound                                                                                            6.9       1.35 × 10^3^      FeL^+^

  Glutathione-[l]{.smallcaps}-DOPA compound                                                                                         6         1.53 × 10^7^      FeHL

  Gly-N-C-DOPA                                                                                                                      6.3       1.07 × 10^4^      FeL^−^

  Guanabenz                                                                                                                         6         2.07 × 10^7^      FeL

  8-HQ-MC-5 (VK28)                                                                                                                  6.9       1.35 × 10^3^      FeL

  4-Hydroxyisophthalic acid                                                                                                         6         3.13 × 10^8^      FeL

  8-hydroxyquinoline                                                                                                                6.9       1.35 × 10^3^      FeL^+^

  8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone                                                                       6.9       1.35 × 10^3^      FeL

  Hydroxy-quinoline-propargyl hybrids (HLA20)                                                                                       6.9       1.35 × 10^3^      FeL

  Hydroxytyrosol butyrate                                                                                                           6         1.53 × 10^7^      FeHL^+^

  Isochlorogenic acid                                                                                                               6         2.93 × 10^6^      FeHL

  KR33493                                                                                                                           6         1.20 × 10^7^      FeL

  Kukoamine                                                                                                                         6         1.53 × 10^7^      FeHL

  Lestaurtinib                                                                                                                      6         2.07 × 10^7^      FeL

  M10\                                                                                                                              6.9       1.35 × 10^3^      FeL
  M30 (VAR10303)\                                                                                                                                               
  M99                                                                                                                                                           

  Macranthoin G                                                                                                                     6         1.53 × 10^7^      FeHL

  Magnesium lithospermate B                                                                                                         6         1.53 × 10^7^      FeHL

  *α*-mangostin                                                                                                                     6         1.53 × 10^7^      FeHL

  *γ*-mangostin                                                                                                                     6         1.53 × 10^7^      FeHL

  MAOI-1                                                                                                                            9.9       1.09              FeL~2~

  MAOI-2                                                                                                                            6         2.07 × 10^7^      FeL

  Meclofenamic acid                                                                                                                 6         2.53 × 10^15^     FeL~2~

  Mildronate                                                                                                                        6         2.53 × 10^15^     FeL~2~

  Mitomycin C                                                                                                                       6         6.57 × 10^7^      FeL

  \[18F\]MPPF                                                                                                                       6         2.07 × 10^7^      FeL

  Nitecapone                                                                                                                        12.7      1.65 × 10^−3^     FeL~2~^2−^

  Nordihydroguaiaretic acid                                                                                                         6         1.53 × 10^7^      FeHL

  Oleuropein                                                                                                                        6         1.53 × 10^7^      FeHL^+^

  Opicapone                                                                                                                         12.7      1.65 × 10^−3^     FeL~2~

  PBF-509                                                                                                                           6         2.07 × 10^7^      FeL

  PBT2                                                                                                                              6.9       1.35 × 10^3^      FeL

  PBT434                                                                                                                            6.2       1.80 × 10^4^      FeL^+^

  Petunidin                                                                                                                         6         1.53 × 10^7^      FeHL

  Phenothiazine 2Bc (n=0)                                                                                                           6         2.07 × 10^7^      FeL^2+^

  Phenylhydroxamates                                                                                                                6         5.96 × 10^7^      FeL~2~

  Piceatannol                                                                                                                       6         1.53 × 10^7^      FeHL

  Piperazine-8-OH-quinolone hybrid                                                                                                  6.9       1.35 × 10^3^      FeL

  Preladenant                                                                                                                       6         2.07 × 10^7^      FeL

  Promethazine                                                                                                                      6         2.07 × 10^7^      FeL^2+^

  Protosappanin A                                                                                                                   6         1.53 × 10^7^      FeHL

  Pyridoxal isonicotinoyl hydrazone (PIH)                                                                                           7.1       6.37 × 10^2^      FeH~2~L~2~

  Pyridoxal isonicotinoyl hydrazone derivatives:\                                                                                   7.1       6.37 × 10^2^      FeH~2~L~2~^2+^
  PCIH\                                                                                                                                                         
  PCTH\                                                                                                                                                         
  H2NPH\                                                                                                                                                        
  H2PPH                                                                                                                                                         

  Pyrimidinone 8                                                                                                                    6         2.07 × 10^7^      FeL

  Q1\                                                                                                                               6.9       1.35 × 10^3^      FeL
  Q4                                                                                                                                                            

  Radotinib                                                                                                                         6.1       4.62 × 10^4^      FeL~2~

  Riboflavin                                                                                                                        6         1.22 × 10^5^      FeL^2+^

  Rifampicin (ASI-3)                                                                                                                6         4.07 × 10^8^      FeL

  Rimonabant                                                                                                                        6         4.85 × 10^11^     FeL

  Rosmarinic acid                                                                                                                   6         1.53 × 10^7^      FeLH

  Salicylate, sodium salt                                                                                                           6         3.13 × 10^8^      FeL

  Salvianolic acid B                                                                                                                6         1.53 × 10^7^      FeHL

  SCH58261SCH412348                                                                                                                 6         2.07 × 10^7^      FeL

  ST1535\                                                                                                                           6         2.07 × 10^7^      FeL
  ST4206                                                                                                                                                        

  Staurosporine                                                                                                                     6         2.07 × 10^7^      FeL

  Sulfuretin                                                                                                                        6         1.53 × 10^7^      FeHL

  Tanshinol                                                                                                                         6         1.53 × 10^7^      FeHL

  Tetracycline                                                                                                                      6         2.73 × 10^6^      FeL

  Tolcapone (ASI-7)                                                                                                                 12.7      1.65 × 10^−3^     FeL~2~^2−^

  Transilitin                                                                                                                       6         1.53 × 10^7^      FeHL

  2′,3′,4′-trihydroxyflavone                                                                                                        9.9       1.09              FeL~2~^2−^

  2,3,3-trisphosphonate                                                                                                             10.7      1.95 × 10^−1^     FeL

  V81444                                                                                                                            6         2.77 × 10^6^      FeL

  Verbascoside                                                                                                                      6         2.02 × 10^6^      FeL

  WIN 55, 212-2                                                                                                                     6         2.07 × 10^7^      FeL^2+^
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

biomolecules-09-00269-t007_Table 7

###### 

pMn(II) and *K*~d~ values, and the most abundant Mn(II) complex, obtained at physiologically relevant conditions: pH = 7.4, *c*~Mn~ = 10^−6^ mol/L, and *c*~L~ = 10^−5^ mol/L. See caption of [Table 3](#biomolecules-09-00269-t003){ref-type="table"} for other notes.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound Name(s)                                                                                                                  pMn(II)   *K*~d~ (nmol/L)   Most Abundant Complex
  --------------------------------------------------------------------------------------------------------------------------------- --------- ----------------- -----------------------
  7DH\                                                                                                                              6.7       2.35 × 10^3^      MnL^+^
  7MH                                                                                                                                                           

  8A\                                                                                                                               6.7       2.35 × 10^3^      MnL
  8B\                                                                                                                                                           
  8C                                                                                                                                                            

  8E\                                                                                                                               6         2.40 × 10^6^      MnL
  8F                                                                                                                                                            

  *N*-Acetyl cysteine                                                                                                               6         8.97 × 10^5^      MnHL^+^

  ACPT-I                                                                                                                            6         2.25 × 10^8^      MnL

  Alvespimycin                                                                                                                      6         7.61 × 10^8^      MnL^2+^

  Ambroxol                                                                                                                          6.7       2.47 × 10^3^      MnL^+^

  3-(7-amino-5-(cyclohexylamino)-\[1,2,4\]triazolo\[1,5-*a*\]\[1,3,5\]triazin-2-yl)-2-cyanoacrylamide                               6         7.61 × 10^8^      MnL

  Aminothiazoles derivatives as SUMOylation activators                                                                              6         7.64 × 10^7^      MnL

  AMN082                                                                                                                            6         7.61 × 10^8^      MnL^2+^

  Apomorphine                                                                                                                       6         7.16 × 10^8^      MnL

  [l]{.smallcaps}-Arginine                                                                                                          6         1.45 × 10^8^      MnL^2+^

  ASI-1                                                                                                                             6         3.44 × 10^6^      MnL^+^

  ASI-5                                                                                                                             6         7.81 × 10^6^      MnL

  Astilbin                                                                                                                          6         7.16 × 10^8^      MnL

  Azilsartan                                                                                                                        6         3.71 × 10^9^      MnL

  Baicalein                                                                                                                         6         2.62 × 10^7^      MnL

  Benserazide                                                                                                                       6         2.62 × 10^7^      MnL

  (−)-*N*6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-*N*6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]thiazole-2,6-diamine derivatives   6         7.61 × 10^8^      MnL^2+^

  2,2′-bipyridyl                                                                                                                    6         2.40 × 10^6^      MnL^2+^

  4-((5-bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic acid (LX007, ZL006)                                                 6         8.72 × 10^8^      MnL

  C-3 (α carboxyfullerene)                                                                                                          6         5.06 × 10^6^      MnL

  Caffeic acid amide analogues                                                                                                      6         6.62 × 10^7^      MnH~−1~L

  Carbazole-derived compounds                                                                                                       6         7.61 × 10^8^      MnL^2+^

  Carbidopa                                                                                                                         7.6       2.33 × 10^2^      MnHL

  Carnosic acid                                                                                                                     6         7.16 × 10^8^      MnL

  Catechin                                                                                                                          6         7.16 × 10^8^      MnL

  Ceftriaxone                                                                                                                       6         2.25 × 10^8^      MnL

  Celastrol                                                                                                                         6         7.16 × 10^8^      MnL

  CEP1347                                                                                                                           6         3.71 × 10^9^      MnL

  Chebulagic acid                                                                                                                   6         2.62 × 10^7^      MnL

  Chlorogenic acid                                                                                                                  6         3.91 × 10^7^      MnL^−^

  Clioquinol                                                                                                                        6.7       2.35 × 10^3^      MnL^+^

  Clovamide analogues (R~1~ and R~2~ = OH, and/or R~3~ and R~4~ = OH)                                                               6         7.16 × 10^8^      MnL

  "Compound 1"                                                                                                                      6         7.61 × 10^8^      MnL^++^

  "Compound (−)-8a"                                                                                                                 6         7.16 × 10^8^      MnL

  "Compound 21", derivative of 3-methyl-1-(2,4,6-trihydroxyphenyl) butan-1-one                                                      6         2.25 × 10^8^      MnL^+^

  "Compound (−)-21a", derivative of *N*-6-(2-(4-(1*H*\                                                                              6         7.61 × 10^8^      MnL^++^
  -indol-5-yl)piperazin-1-yl)ethyl)-*N*-6-propyl-4,5,6,7-tetrahydrobenzo\[*d*\]thiazole-2,6-diamine                                                             

  Creatine                                                                                                                          6         2.25 × 10^8^      MnL^+^

  Curcumin                                                                                                                          6         3.44 × 10^6^      MnL

  Cyanidin                                                                                                                          6         7.16 × 10^8^      MnL

  D512                                                                                                                              6         7.61 × 10^8^      MnL^2+^

  D607 (bipyridyl-D2R/D3R agonist hybrid)                                                                                           6         2.40 × 10^6^      MnL

  DA-2 (8D)                                                                                                                         6.7       2.35 × 10^3^      MnL

  DA-3                                                                                                                              6         7.61 × 10^8^      MnL

  DA-4                                                                                                                              6         7.61 × 10^8^      MnL

  Dabigatran etexilate                                                                                                              6         7.61 × 10^8^      MnL

  (*S*)-3,4-DCPG                                                                                                                    6         5.91 × 10^6^      MnL

  Delphinidin                                                                                                                       6         2.62 × 10^7^      MnL

  Demethoxycurcumin                                                                                                                 6         3.44 × 10^6^      MnL

  Dendropanax morbifera active compound                                                                                             6         7.16 × 10^8^      MnL

  4,5-*O*-Dicaffeoyl-1-*O*-(malic acid methyl ester)-quinic acid derivatives (R~1~, R~2~, R~3~, R~4~, or R~5~ = caffeoyl)           6         7.16 × 10^8^      MnL

  Dihydromyricetin                                                                                                                  6         2.62 × 10^7^      MnL

  5-(3,4-Dihydroxybenzylidene) -2,2-dimethyl-1,3-dioxane-4,6-dione                                                                  6         7.16 × 10^8^      MnL

  7,8-Dihydroxycoumarin derivative DHC12                                                                                            6         7.16 × 10^8^      MnL

  3′,4′-Dihydroxyflavone                                                                                                            6         7.16 × 10^8^      MnL

  7,8-dihydroxyflavone                                                                                                              6         7.16 × 10^8^      MnL

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfones                                                                                        6         7.16 × 10^8^      MnL

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfoxides                                                                                      6         7.16 × 10^8^      MnL

  2-\[\[(1,1-Dimethylethyl) oxidoimino\]-methyl\]-3,5,6-trimethylpyrazine                                                           6         2.58 × 10^6^      MnL

  DKP                                                                                                                               6         1.00 × 10^6^      MnHL

  [l]{.smallcaps}-DOPA (levodopa, CVT-301)                                                                                          7.6       2.26 × 10^2^      MnHL

  DOPA-derived peptido-mimetics (deprotected)                                                                                       7.6       2.33 × 10^2^      MnHL

  DOPA-derived peptido-mimetics (protected)                                                                                         6         7.16 × 10^8^      MnL

  [l]{.smallcaps}-dopa deuterated                                                                                                   7.6       2.26 × 10^2^      MnHL

  Droxidopa                                                                                                                         7.6       2.33 × 10^2^      MnHL

  Echinacoside                                                                                                                      6         7.16 × 10^8^      MnL

  Ellagic acid                                                                                                                      6         7.16 × 10^8^      MnL

  Entacapone (comtan, ASI-6)                                                                                                        6         6.74 × 10^5^      MnL

  Enzastaurin                                                                                                                       6         7.61 × 10^8^      MnL

  Epicatechin                                                                                                                       6         7.16 × 10^8^      MnL

  Etidronate (HEDPA)                                                                                                                6         1.03 × 10^6^      MnL^2−^

  F13714\                                                                                                                           6         7.64 × 10^7^      MnL
  F15599                                                                                                                                                        

  Fisetin (3,3′,4′,7-tetra-hydroxy-flavone)                                                                                         6         7.16 × 10^8^      MnL

  Fraxetin                                                                                                                          6         7.16 × 10^8^      MnL

  Gallocatechin                                                                                                                     6         2.62 × 10^7^      MnL

  Garcinol                                                                                                                          6         7.16 × 10^8^      MnL

  Glutamine                                                                                                                         6         2.30 × 10^7^      MnL^+^

  Glutathione derivatives                                                                                                           6         4.07 × 10^5^      MnL^−^

  Glutathione-hydroxy-quinoline compound                                                                                            6.7       2.35 × 10^3^      MnL^+^

  Glutathione-[l]{.smallcaps}-DOPA compound                                                                                         6         7.16 × 10^8^      MnL

  Gly-N-C-DOPA                                                                                                                      7.6       2.33 × 10^2^      MnHL

  Guanabenz                                                                                                                         6         7.61 × 10^8^      MnL

  Hinokitiol                                                                                                                        6.1       2.99 × 10^4^      MnL^+^

  8-HQ-MC-5 (VK-28)                                                                                                                 6.7       2.35 × 10^3^      MnL

  4-Hydroxyisophthalic acid                                                                                                         6         8.72 × 10^8^      MnL

  8-hydroxyquinoline                                                                                                                6.7       2.35 × 10^3^      MnL^+^

  8-Hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone                                                                       6.7       2.35 × 10^3^      MnL

  Hydroxy-quinoline-propargyl hybrids (HLA20)                                                                                       6.7       2.35 × 10^3^      MnL

  Hydroxytyrosol butyrate                                                                                                           6         7.16 × 10^8^      MnL

  Isobavachalcone                                                                                                                   6.2       1.55 × 10^4^      MnL^+^

  Isochlorogenic acid                                                                                                               6         3.91 × 10^7^      MnL^−^

  KR33493                                                                                                                           6         2.25 × 10^8^      MnL

  Kukoamine                                                                                                                         6         7.16 × 10^8^      MnL

  Lestaurtinib                                                                                                                      6         7.61 × 10^8^      MnL

  Lipoic acid                                                                                                                       6         9.53 × 10^6^      MnL^+^

  Luteolin                                                                                                                          6         7.16 × 10^8^      MnL

  M10\                                                                                                                              6.7       2.35 × 10^3^      MnL
  M30 (VAR10303)\                                                                                                                                               
  M99                                                                                                                                                           

  Macranthoin G                                                                                                                     6         7.16 × 10^8^      MnL

  Magnesium lithospermate B                                                                                                         6         7.16 × 10^8^      MnL

  α-mangostin                                                                                                                       6         7.16 × 10^8^      MnL

  γ-mangostin                                                                                                                       6         7.16 × 10^8^      MnL

  MAOI-1                                                                                                                            6         2.62 × 10^7^      MnL

  MAOI-2                                                                                                                            6         7.61 × 10^8^      MnL

  Meclofenamic acid                                                                                                                 6         3.71 × 10^9^      MnL

  Mildronate                                                                                                                        6         3.71 × 10^9^      MnL

  Mitomycin C                                                                                                                       6         7.46 × 10^7^      MnL

  MitoQ                                                                                                                             6         1.29 × 10^5^      MnL

  \[18F\]MPPF                                                                                                                       6         7.61 × 10^8^      MnL

  Nicotinamide adenine dinucleotide phosphate (NADPH)                                                                               6         2.01 × 10^7^      MnL

  Nicotinamide mononucleotide                                                                                                       6         6.59 × 10^6^      MnL

  Nitecapone                                                                                                                        6         6.74 × 10^5^      MnL

  Nordihydroguaiaretic acid                                                                                                         6         7.16 × 10^8^      MnL

  Oleuropein                                                                                                                        6         7.16 × 10^8^      MnL

  Opicapone                                                                                                                         6         6.74 × 10^5^      MnL

  PBF-509                                                                                                                           6         2.41 × 10^9^      MnL

  PBT2                                                                                                                              6         5.22 × 10^5^      MnL^+^

  Petunidin                                                                                                                         6         7.16 × 10^8^      MnL

  Phenothiazine 2Bc (n=0)                                                                                                           6         7.61 × 10^8^      MnL^2+^

  Phenylhydroxamates                                                                                                                6         5.81 × 10^6^      MnL

  Piceatannol                                                                                                                       6         7.16 × 10^8^      MnL

  Piperazine-8-OH-quinolone hybrid                                                                                                  6.7       2.35 × 10^3^      MnL

  Preladenant                                                                                                                       6         7.61 × 10^8^      MnL

  Promethazine                                                                                                                      6         7.61 × 10^8^      MnL^2+^

  Protocatechuic acid                                                                                                               6         3.66 × 10^8^      MnL^−^

  Protosappanin A                                                                                                                   6         7.16 × 10^8^      MnL

  Pyrimidinone 8                                                                                                                    6         7.61 × 10^8^      MnL

  Q1\                                                                                                                               6.7       2.35 × 10^3^      MnL
  Q4                                                                                                                                                            

  Radotinib                                                                                                                         6         2.40 × 10^6^      MnL

  Riboflavin                                                                                                                        6         5.75 × 10^5^      MnHL^3+^

  Rifampicin (ASI-3)                                                                                                                6         1.03 × 10^6^      MnL

  Rimonabant                                                                                                                        6         1.00 × 10^6^      MnHL

  Rosmarinic acid                                                                                                                   6         7.16 × 10^8^      MnL

  Salicylate, sodium salt                                                                                                           6         8.72 × 10^8^      MnL

  Salvianolic acid B                                                                                                                6         7.16 × 10^8^      MnL

  SCH58261\                                                                                                                         6         7.61 × 10^8^      MnL
  SCH412348                                                                                                                                                     

  ST1535\                                                                                                                           6         7.61 × 10^8^      MnL
  ST4206                                                                                                                                                        

  Staurosporine                                                                                                                     6         7.61 × 10^8^      MnL

  Sulfuretin                                                                                                                        6         7.16 × 10^8^      MnL

  Tanshinol                                                                                                                         6         7.16 × 10^8^      MnL

  Taurine                                                                                                                           6         6.39 × 10^11^     MnL~2~

  Tetracycline                                                                                                                      6         2.14 × 10^7^      MnL

  Tolcapone (ASI-7)                                                                                                                 6         6.74 × 10^5^      MnL

  Transilitin                                                                                                                       6         7.16 × 10^8^      MnL

  2′,3′,4′-Trihydroxyflavone                                                                                                        6         2.62 × 10^7^      MnL

  V81444                                                                                                                            6         7.64 × 10^7^      MnL

  Verbascoside                                                                                                                      6         6.62 × 10^7^      MnH~−1~L

  WIN 55,212-2                                                                                                                      6         7.61 × 10^8^      MnL^2+^
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

biomolecules-09-00269-t008_Table 8

###### 

pZn(II) and *K*~d~ values, and the most abundant Zn(II) complex, obtained at physiologically relevant conditions: pH = 7.4, *c*~Zn~ = 10^−6^ mol/L, and *c*~L~ = 10^−5^ mol/L. See caption of [Table 3](#biomolecules-09-00269-t003){ref-type="table"} for other notes.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound Name(s)                                                                                                                pZn(II)   *K*~d~ (nmol/L)   Most Abundant Complex
  ------------------------------------------------------------------------------------------------------------------------------- --------- ----------------- -----------------------
  7DH\                                                                                                                            7.5       3.16 × 10^2^      ZnL
  7MH                                                                                                                                                         

  8A\                                                                                                                             7.5       3.16 × 10^2^      ZnL
  8B\                                                                                                                                                         
  8C                                                                                                                                                          

  8E\                                                                                                                             6.4       6.31 × 10^3^      ZnL
  8F                                                                                                                                                          

  *N*-acetyl cystein                                                                                                              6         1.66 × 10^6^      ZnL

  ACPT-I                                                                                                                          6         1.46 × 10^7^      ZnL

  Alaternin                                                                                                                       6.8       1.83 × 10^3^      ZnL

  Alvespimycin                                                                                                                    6         7.85 × 10^5^      ZnL^2+^

  AM-251                                                                                                                          6         1.95 × 10^6^      ZnHL

  Ambroxol                                                                                                                        7.7       1.90 × 10^2^      ZnL~2~

  3-(7-amino-5-(cyclohexylamino)-\[1,2,4\]triazolo\[1,5-*a*\]\[1,3,5\]triazin-2-yl)-2-cyanoacrylamide                             6         7.85 × 10^5^      ZnL

  Aminothiazoles derivatives as SUMOylation activators                                                                            6         2.28 × 10^5^      ZnL

  AMN082                                                                                                                          6         7.85 × 10^5^      ZnL^2+^

  Antagonist of the A(2A) adenosine receptor - derivative 49                                                                      6         1.95 × 10^6^      ZnHL

  Apigenin                                                                                                                        6         1.23 × 10^29^     ZnH~3~L

  Apomorphine                                                                                                                     6         7.76 × 10^6^      ZnL

  [l]{.smallcaps}-Arginine                                                                                                        6         4.14 × 10^6^      ZnL^2+^

  Ascorbic acid                                                                                                                   6.1       4.67 × 10^4^      ZnL^+^

  ASI-1                                                                                                                           6         5.76 × 10^5^      ZnL^+^

  ASI-5                                                                                                                           6         9.06 × 10^6^      ZnL

  Astilbin                                                                                                                        6         7.76 × 10^6^      ZnL

  Azilsartan                                                                                                                      6         5.22 × 10^5^      ZnL

  Baicalein                                                                                                                       6         2.71 × 10^5^      ZnL

  Benserazide                                                                                                                     6         2.71 × 10^5^      ZnL

  7*H*-Benzo\[*e*\] perimidin-7-one derivatives (R~6~ = OH)                                                                       6.1       4.82 × 10^4^      ZnL~2~

  4*H*-1-benzopyran-4-one                                                                                                         6         3.56 × 10^20^     ZnH~3~L

  8-Benzyl-tetrahydropyrazino\[2,1-*f*\]purinedione (derivative n. 57)                                                            6         9.67 × 10^11^     ZnL

  Bikaverin                                                                                                                       6.3       1.07 × 10^4^      ZnH~−2~L^2−^

  (−)-*N*6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-*N*6-propyl-4,5,6,7-tetrahydrobenzo\[d\]thiazole-2,6-diamine derivatives   6         7.85 × 10^5^      ZnL^2+^

  2,2′-bipyridyl                                                                                                                  6.4       6.31 × 10^3^      ZnL^2+^

  4-((5-Bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic acid (LX007, ZL006)                                               6         8.04 × 10^8^      ZnH~−1~L

  C-3 (α carboxyfullerene)                                                                                                        6         2.08 × 10^6^      ZnL

  Caffeic acid amide analogues                                                                                                    6         9.29 × 10^5^      ZnH~−1~L

  Carbazole-derived compounds                                                                                                     6         7.85 × 10^5^      ZnL^2+^

  Carbidopa                                                                                                                       6         2.96 × 10^6^      ZnHL

  Carnosic acid                                                                                                                   6         7.76 × 10^6^      ZnL

  Cathechin                                                                                                                       6         7.76 × 10^6^      ZnL

  Ceftriaxone                                                                                                                     6.1       3.68 × 10^4^      ZnL

  Celastrol                                                                                                                       6         7.76 × 10^6^      ZnL

  Chebulagic acid                                                                                                                 6         1.81 × 10^13^     Zn~2~L

  Chlorogenic acid                                                                                                                6         6.86 × 10^5^      ZnL^−^

  3′-*O*-(3-Chloropivaloyl) quercetin                                                                                             6         5.69 × 10^16^     ZnH~3~L

  Chlorpromazine                                                                                                                  6         1.95 × 10^6^      ZnHL^3+^

  Chrysin                                                                                                                         6         5.69 × 10^16^     ZnH~3~L

  Clioquinol                                                                                                                      7.5       3.16 × 10^2^      ZnL^+^

  Clovamide analogues (R~1~ and R~2~ = OH, and/or R~3~ and R~4~ = OH)                                                             6         7.76 × 10^6^      ZnL

  "Compound 1"                                                                                                                    6         7.85 × 10^5^      ZnL^2+^

  "Compound (−)-8a"                                                                                                               6         7.76 × 10^6^      ZnL

  "Compound 8"                                                                                                                    6.4       6.47 × 10^3^      ZnH~−1~L

  "Compound 21", derivative of 3-methyl-1-(2,4,6-trihydroxyphenyl) butan-1-one                                                    6         1.54 × 10^6^      ZnL^+^

  "Compound (−)-21a", derivative of *N*-6-(2-(4-(1*H*\                                                                            6         7.85 × 10^5^      ZnL^2+^
  -indol-5-yl)piperazin-1-yl)ethyl)-*N*-6-propyl-4,5,6,7-tetrahydrobenzo\                                                                                     
  \[*d*\]thiazole-2,6-diamine                                                                                                                                 

  Creatine                                                                                                                        6         1.54 × 10^6^      ZnL^+^

  Cudraflavone B                                                                                                                  6         5.69 × 10^16^     ZnH~3~L

  Curcumin                                                                                                                        6         5.76 × 10^5^      ZnL

  Cyanidin                                                                                                                        6         7.76 × 10^6^      ZnL

  D512                                                                                                                            6         7.85 × 10^5^      ZnL^2+^

  D607 (bipyridyl-D2R/D3R agonist hybrid)                                                                                         6.4       6.31 × 10^3^      ZnL

  DA-2 (8D)                                                                                                                       7.5       2.80 × 10^2^      ZnL

  DA-3                                                                                                                            6         7.85 × 10^5^      ZnL

  DA-4                                                                                                                            6         7.85 × 10^5^      ZnL

  Dabigatran etexilate                                                                                                            6         7.85 × 10^5^      ZnL

  Dabrafenib                                                                                                                      6         8.23 × 10^7^      ZnL

  (*S*)-3,4-DCPG                                                                                                                  6         6.84 × 10^6^      ZnL

  Deferricoprogen                                                                                                                 8.3       4.35 × 10^1^      ZnHL

  Delphinidin                                                                                                                     6         2.71 × 10^5^      ZnL

  Demethoxycurcumin                                                                                                               6         5.76 × 10^5^      ZnL

  Dendropanax morbifera active compound                                                                                           6         7.76 × 10^6^      ZnL

  Desferrioxamine (Deferoxamine, Desferal, DFO)                                                                                   7.4       3.97 × 10^2^      ZnH~2~L^+^

  (*S*)-*N*-(3-(3,6-Dibromo-9*H*-carbazol-9-yl)-2-fluoropropyl)\                                                                  6         1.95 × 10^6^      ZnHL
  -6-methoxypyridin-2-amine                                                                                                                                   

  4,5-*O*-Dicaffeoyl-1-*O*-(malic acid methyl ester)-quinic acid derivatives (R~1~, R~2~, R~3~, R~4~, or R~5~ = caffeoyl)         6         7.76 × 10^6^      ZnL

  Dihydromyricetin                                                                                                                6         2.71 × 10^5^      ZnL

  5-(3,4-Dihydroxybenzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione                                                                 6         7.76 × 10^6^      ZnL

  7,8-Dihydroxycoumarin derivative DHC12                                                                                          6         7.76 × 10^6^      ZnL

  3′,4′-Dihydroxyflavone                                                                                                          6         7.76 × 10^6^      ZnL

  7,8-Dihydroxyflavone                                                                                                            6         7.76 × 10^6^      ZnL

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfones                                                                                      6         7.76 × 10^6^      ZnL

  (*E*)-3,4-Dihydroxystyryl aralkyl sulfoxides                                                                                    6         7.76 × 10^6^      ZnL

  2-\[\[(1,1-Dimethylethyl) oxidoimino\]-methyl\]-3,5,6-trimethylpyrazine                                                         6         2.20 × 10^6^      ZnL

  DKP                                                                                                                             6         1.52 × 10^6^      ZnL

  [l]{.smallcaps}-DOPA (levodopa, CVT-301)                                                                                        6         2.96 × 10^6^      ZnHL

  DOPA-derived peptido-mimetics (deprotected)                                                                                     6         2.96 × 10^6^      ZnHL

  DOPA-derived peptido-mimetics (protected)                                                                                       6         7.76 × 10^6^      ZnL

  [l]{.smallcaps}-dopa deuterated                                                                                                 6         2.96 × 10^6^      ZnHL

  Doxycycline                                                                                                                     6.1       3.88 × 10^4^      ZnL

  Droxidopa                                                                                                                       10.9      1.18 × 10^−1^     ZnHL

  Echinacoside                                                                                                                    6         7.76 × 10^6^      ZnL

  Ellagic acid                                                                                                                    6         7.76 × 10^6^      ZnL

  Entacapone (comtan, ASI-6)                                                                                                      6.2       2.62 × 10^4^      ZnL

  Enzastaurin                                                                                                                     6         7.85 × 10^5^      ZnL

  Epicatechin                                                                                                                     6         7.76 × 10^6^      ZnL

  Epigallocatechin-3-gallate                                                                                                      6         1.81 × 10^13^     Zn~2~L

  Etidronate (HEDPA)                                                                                                              7.4       4.32 × 10^2^      ZnL^2−^

  Exifone                                                                                                                         6         1.81 × 10^13^     Zn~2~L

  F13714,\                                                                                                                        6         2.28 × 10^5^      ZnL
  F15599                                                                                                                                                      

  Fisetin (3,3′,4′,7-tetra-hydroxy-flavone)                                                                                       6         7.76 × 10^6^      ZnL

  Fraxetin                                                                                                                        6         7.76 × 10^6^      ZnL

  Gallic acid derivatives                                                                                                         6         1.81 × 10^13^     Zn~2~L

  Gallocatechin                                                                                                                   6         2.71 × 10^5^      ZnL

  Garcinol                                                                                                                        6         7.76 × 10^6^      ZnL

  Glutamine                                                                                                                       6         8.61 × 10^5^      ZnL^+^

  Glutathione derivatives                                                                                                         14.8      1.20 × 10^−5^     ZnH~−2~L~2~^2−^

  Glutathione-hydroxy-quinoline compound                                                                                          7.8       1.37 × 10^2^      ZnH~−1~L^+^

  Glutathione-[l]{.smallcaps}-DOPA compound                                                                                       6.3       1.20 × 10^4^      ZnH~−1~L

  Gly-N-C-DOPA                                                                                                                    6         2.96 × 10^6^      ZnHL

  GSK2795039                                                                                                                      9.7       1.64              ZnL~2~

  Guanabenz                                                                                                                       6         7.85 × 10^5^      ZnL

  Hinokitiol                                                                                                                      6.2       2.06 × 10^4^      ZnL^+^

  8-HQ-MC-5 (VK-28)                                                                                                               7.5       3.16 × 10^2^      ZnL

  4-Hydroxyisophthalic acid                                                                                                       6         9.02 × 10^7^      ZnL

  1-Hydroxy-2-pyridinone derivatives                                                                                              6.3       1.01 × 10^4^      ZnL

  3-Hydroxy-4(1*H*)pyridinone (Deferiprone)                                                                                       6.2       1.45 × 10^4^      ZnL^+^

  3-Hydroxy-4(1*H*)pyridinone derivatives (R = H)                                                                                 6.2       1.45 × 10^4^      ZnL

  8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone                                                                     7.5       3.16 × 10^2^      ZnL

  Hydroxy-quinoline-propargyl hybrids (HLA20)                                                                                     7.5       3.16 × 10^2^      ZnL

  Hydroxytyrosol butyrate                                                                                                         6         7.76 × 10^6^      ZnL

  l-(7-Imino-3-propyl-2,3-dihydrothiazolo \[4,5-*d*\]\                                                                            6.5       5.10 × 10^3^      ZnH~−1~L
  pyrimidin-6(7*H*)-yl)urea                                                                                                                                   

  Imipramine                                                                                                                      6         1.95 × 10^6^      ZnHL^3+^

  Isobavachalcone                                                                                                                 6         2.12 × 10^5^      ZnL^+^

  Isochlorogenic acid                                                                                                             6         6.86 × 10^5^      ZnL^−^

  Isoquercetin (isoquercitrin)                                                                                                    6         3.94 × 10^24^     ZnH~4~L

  Kaempferol                                                                                                                      6         3.94 × 10^24^     ZnH~4~L^+^

  Kaempferol, 3-*O*-a-L arabino-furanoside-7-*O*-a-\                                                                              6         3.56 × 10^20^     ZnH~3~L
  L-rhamno-pyranoside                                                                                                                                         

  KR33493                                                                                                                         6         1.54 × 10^6^      ZnL

  Kukoamine                                                                                                                       6         7.76 × 10^6^      ZnL

  Lestaurtinib                                                                                                                    6         7.85 × 10^5^      ZnL

  Lipoic acid                                                                                                                     6         3.84 × 10^6^      ZnL^+^

  LY354740                                                                                                                        6         1.46 × 10^7^      ZnL

  M10\                                                                                                                            7.5       3.16 × 10^2^      ZnL
  M30 (VAR10303)\                                                                                                                                             
  M99                                                                                                                                                         

  Macranthoin G                                                                                                                   6         7.76 × 10^6^      ZnL

  Magnesium lithospermate B                                                                                                       6         7.76 × 10^6^      ZnL

  α-mangostin                                                                                                                     6         7.76 × 10^6^      ZnL

  γ- mangostin                                                                                                                    6         7.76 × 10^6^      ZnL

  MAOI-1                                                                                                                          6         2.71 × 10^5^      ZnL

  MAOI-2                                                                                                                          6         7.85 × 10^5^      ZnL

  MAOI-4                                                                                                                          6         5.88 × 10^5^      ZnHL

  Metformin (Met)                                                                                                                 6         1.87 × 10^6^      ZnL^+^

  Methoxy-6-acetyl-7-methylijuglone                                                                                               6.1       4.82 × 10^4^      ZnL~2~

  *N*′-(4-methylbenzylidene)-5-phenylisoxazole-3-carbohydrazide                                                                   6         1.76 × 10^6^      ZnL

  Minocycline                                                                                                                     6.4       7.52 × 10^3^      ZnHL

  Mitomycin C                                                                                                                     6         3.49 × 10^6^      ZnL

  MitoQ                                                                                                                           7.1       8.74 × 10^2^      ZnL

  Morin                                                                                                                           6         5.69 × 10^16^     ZnH~3~L

  \[18F\]MPPF                                                                                                                     6         7.85 × 10^5^      ZnL

  MSX-3                                                                                                                           6         8.19 × 10^6^      ZnL

  Nicotinamide adenine dinucleotide phosphate (NADPH)                                                                             6.1       3.72 × 10^4^      ZnL

  Nicotinamide mononucleotide                                                                                                     6         8.19 × 10^6^      ZnL

  Nitecapone                                                                                                                      6.2       2.62 × 10^4^      ZnL

  Nordihydroguaiaretic acid                                                                                                       6         7.76 × 10^6^      ZnL

  Oleuropein                                                                                                                      6         7.76 × 10^6^      ZnL

  Opicapone                                                                                                                       6.2       2.62 × 10^4^      ZnL

  P7C3                                                                                                                            6         1.96 × 10^7^      ZnL^2+^

  PBF-509                                                                                                                         6         7.85 × 10^5^      ZnL

  PBT2                                                                                                                            7.5       3.16 × 10^2^      ZnL

  PBT434                                                                                                                          7.9       1.19 × 10^2^      ZnL~2~

  Petunidin                                                                                                                       6         7.76 × 10^6^      ZnL

  Phenothiazine 2Bc (n=0)                                                                                                         6         7.85 × 10^5^      ZnL^2+^

  Phenothiazine 2Bc (n=1)                                                                                                         6         1.95 × 10^6^      ZnHL^3+^

  Phenylhydroxamates                                                                                                              6         2.07 × 10^5^      ZnL

  Piceatannol                                                                                                                     6         7.76 × 10^6^      ZnL

  Piperazine-8-OH-quinolone hybrid                                                                                                7.5       3.16 × 10^2^      ZnL

  Preladenant                                                                                                                     6         7.85 × 10^5^      ZnL

  Promethazine                                                                                                                    6         7.85 × 10^5^      ZnL^2+^

  Protocatechuic acid                                                                                                             6         1.25 × 10^7^      ZnL^−^

  Protosappanin A                                                                                                                 6         7.76 × 10^6^      ZnL

  Pyrazolobenzothiazine-based carbothioamides                                                                                     6         4.73 × 10^7^      ZnL

  Pyrimidinone 8                                                                                                                  6         7.85 × 10^5^      ZnL

  Q1\                                                                                                                             7.5       3.16 × 10^2^      ZnL
  Q4                                                                                                                                                          

  Quercetin                                                                                                                       6         3.94 × 10^24^     ZnH~4~L^+^

  Quinoline derivatives as SUMOylation activators                                                                                 6         3.94 × 10^6^      ZnL^2+^

  Radotinib                                                                                                                       6.4       6.31 × 10^3^      ZnL

  Riboflavin                                                                                                                      6         2.16 × 10^5^      ZnHL^3+^

  Rifampicin (ASI-3)                                                                                                              6.1       7.04 × 10^4^      ZnL

  Rimonabant                                                                                                                      6         1.52 × 10^6^      ZnL

  Rosmarinic acid                                                                                                                 6         7.76 × 10^6^      ZnL

  Rutin                                                                                                                           6         3.94 × 10^24^     ZnH~4~L^+^

  Salicylate, sodium salt                                                                                                         6         9.02 × 10^7^      ZnL

  Salvianolic acid B                                                                                                              6         7.76 × 10^6^      ZnL

  SCH58261\                                                                                                                       6         7.85 × 10^5^      ZnL
  SCH412348                                                                                                                                                   

  ST1535 ST4206                                                                                                                   6         7.85 × 10^5^      ZnL

  Staurosporine                                                                                                                   6         7.85 × 10^5^      ZnL

  Stemazole                                                                                                                       6         4.73 × 10^7^      ZnL

  Sulfuretin                                                                                                                      6         7.76 × 10^6^      ZnL

  Tannic acid                                                                                                                     6         1.22 × 10^5^      ZnL

  Tanshinol                                                                                                                       6         7.76 × 10^6^      ZnL

  Taurine                                                                                                                         6         1.26 × 10^12^     ZnL~2~

  Tetracycline                                                                                                                    6         7.01 × 10^6^      ZnL

  Tolcapone (ASI-7)                                                                                                               6.2       2.62 × 10^4^      ZnL

  Tozadenant                                                                                                                      8.7       1.62 × 10^1^      ZnL~2~

  Transilitin                                                                                                                     6.1       8.21 × 10^4^      ZnL

  o-Trensox                                                                                                                       21.7      1.95 × 10^−12^    ZnL^4−^

  2′, 3′, 4′-Trihydroxyflavone                                                                                                    6         2.71 × 10^5^      ZnL

  2,3,3-Trisphosphonate                                                                                                           12.1      7.93 × 10^−3^     ZnL

  V81444                                                                                                                          6         2.28 × 10^5^      ZnL

  VAS3947\                                                                                                                        6.5       5.10 × 10^3^      ZnH~−1~L
  VAS2870                                                                                                                                                     

  Verbascoside                                                                                                                    6         9.29 × 10^5^      ZnH~−1~L

  WIN 55,212-2                                                                                                                    6         7.85 × 10^5^      ZnL^2+^

  WR-1065                                                                                                                         6         1.95 × 10^6^      ZnHL^3+^

  Zonisamide                                                                                                                      8         8.81 × 10^1^      ZnL
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
